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Chapter 1General introduction, hypothesis, and aim of this thesis
10
1. General introduction
Humans are one of the least fertile species on earth (Rushton et al., 1975). Although 
the chance of reaching a pregnancy per cycle is merely around 20% (Macklon et 
al., 2002), we are part of a population of 7.5 billion individuals (EC, 2017). The 
world population has increased around ten-fold in the past 300 years (EC, 2017). 
In the 18th century, Thomas Robert Malthus (Glass and Appleman, 1976) proposed 
that the human population grows exponentially while food production grows at 
a linear rate and therefore resources to sustain human life would become scarce. 
In the 1970’s, when demographic indicators suggested a doubling of the world 
population in the next 36 years (Meadows, 1972), the threat of overpopulation 
induced measures to limit birth rates. Sexual education focussing on prevention 
of pregnancy in early adolescence was introduced in schools (McCall et al., 2015), 
compulsory sterilization was a practice adopted in many countries (Gulhati, 1977; 
Kingma, 2000; McCavitt, 2013) and the one-child-policy was established in China 
(Potts, 2006). As a consequence, teen pregnancy rates dropped in most countries 
in the world (UN, 2015). In China alone, the one-child policy is speculated to have 
prevented 400 million births (Whyte et al., 2015). In parallel with these birth 
control policies, birth rates also dropped impressively by social changes such as 
industrialization and female economic and educational emancipation (Ackerly and 
True, 2010). Additionally, the advances in contraceptive methods provided a major 
improvement in the control of family planning (Planned Parenthood, 2015). 
Figure 1.1 shows the effect of these developments on the global average number 
of children per woman, which dropped from 4.5 in the 1970’s to 2.5 in 2010 (UN, 
2015). Nowadays, in Europe, most countries have birth rates below replacement 
levels (Gissler et al., 2010), that is, an average of less than 2.1 children per woman 
(Geeta Nargund, 2009). Except for France and the UK, most European countries have 
more deaths than births annually (Eurostat, 2008). As a consequence, European 
populations are either growing slowly or shrinking (Eurostat, 2008).
In order to maintain the population size and have a chance of at least 90% of realizing 
a two-child family without using artificial reproduction techniques (ART), couples 
should start trying to conceive when the female partner is 27 years or younger 
(Habbema et al., 2015). However, in the last decades, couples are starting families 
later in life; this is known as the childbearing delay phenomenon (Mills et al., 2011). 
In 2010, 20% of all women from 29 countries in Europe were 35 years or older at 
their first pregnancy, with proportions going as high as 35% in Spain, Switzerland, 











































































































































































































































































































































































































































































































































































































































































It is a couple’s decision if and when to have children and men do not encounter 
much barriers to become fathers at later ages and are able to wait for career 
or economic stability if they wish (Hobson, 2002). The same does not apply for 
women. Economic factors, socio-cultural environment as well as biologic limitations 
influence a woman´s decision to start a family (Hammarberg and Clarke, 2005; Daly 
and Bewley, 2013). In order to enter the work-force, women have to invest time in 
their education. Once employed, the main reason for an interruption in women’s 
employment is the birth of the first child (Bewley, S., Ledger, W., Nikolaou, 2009).
The major issue women encounter when delaying childbearing is the biologic 
limitation of decreasing fertility with age. A substantial proportion of women 
shifted their age at first birth to their mid-thirties, a period in which fecundity, i.e., 
the capacity to conceive, is already declining (see figure 1.2).
Figure 1.2: The decrease in monthly fecundity rate relative to the fecundity rate of women 
in the 20-30 year age group.
Footnote: fecundity rate is the rate of live born children. Source: Trends in Endocrinology and 
Metabolism, 2007; 18:58-65 (Reproduced with permission of the copyright owner)
Fecundity is estimated to start declining after 30 years of age (van Noord-Zaadstra et 
al., 1991; Broekmans et al., 2007). The course of decline in fecundity with advancing 
female age is not well-known among women and men in all fertile age groups and 
women in the reproductive period of their lives overestimate their fecundity and 
the efficacy of ART(Delbaere et al., 2015; Balbo, Billari & Mills, 2013). For example, 
women of various ages in the Flemish region believe that fecundity starts to decrease 
at age 50 and the majority believes that the chance of becoming pregnant after one 
IVF cycle is 40-100% (Delbaere et al., 2015). In reality, the live birth rates per cycle 
13
1for women undergoing ART is around 40% for women younger than 30 years and 20% for women older than 36 years (McLernon et al., 2016; Toftager et al., 2017). 
The explanation for the biological limitations to achieve a healthy life birth later in 




The origins of the reproductive system lie very early in embryonic life, during the 
second week post conception. Around this time, the cells from which the female 
gametes originate, the so-called primordial germ cells (PGCs), are first observed 
at the endoderm and yolk sac of the developing embryo (Schoenwolf et al., 2014). 
These PGCs migrate to the developing gonadal ridges, where they proliferate and 
differentiate into oogonias (figure 2.1). The mitotic proliferation of oogonias ends 
around 20 weeks after conception, when the estimated number of oogonias, already 
diminished at this point via atresia, is around 300,000-800,000. The oogonias 
differentiate into primary oocytes via meiotic divisions which do not go further 
than the cellular division. The oocytes are surrounded by one layer of somatic cells, 
the granulosa cells (Coticchio et al., 2013). The complex of the oocyte surrounded 
by granulosa cells is called a primordial follicle, in which the oocyte is arrested in 
the diplotene phase of the prophase of meiosis I, the resting phase. These resting 
primordial follicles are also known as the non-growing follicles (NGFs) or follicle 
pool. The quantity of NGFs a female neonate is born with is the fixed initial supply 
of oocytes that she has available for the rest of her life (Depmann et al., 2015).
2b.The ovarian reserve throughout life
Although there are researchers exploring the possibility of female PGCs’ replication 
after birth (Johnson et al., 2004; Tilly and Telfer, 2009), the predominant concept is 
that the proliferation via mitotic division of oogonias occurs only in the embryonic 
period and that their number decreases steadily after that. Throughout life, women 
lose oocytes by two mechanisms: atresia via apoptosis and ovulation (Markström et 
al., 2002). Atresia starts already before birth since not all oogonias enter meiosis and 
develop into oocytes; but many undergo atresia. This process continues throughout 
the reproductive lifespan (Forabosco and Sforza, 2007) (figure 2.2). It is estimated 
that throughout a woman’s normal reproductive lifespan, only about 400 follicles 
complete ovulation (Gougeon, 1994); the vast majority of follicles will undergo
14
Figure 2.1- Chronology of human primordial germ cell development. Source: Coticchio et 
al.,2013. Oogenesis, ISBN:978085729856 (Reproduced with permission of the copyright 
owner)
atresia. The rate of follicle loss seems to be relatively constant and does not seem to 
change during puberty, pregnancy, lactation or under the influence of contraceptives 
steroids (Bewley, S., Ledger, W., Nikolaou, 2009). However, in the perimenopausal 
period, the rate of depletion doubles (Faddy et al., 1992). The function of this 
programmed cell death throughout a woman’s life is not fully comprehended. Some 
authors argue it is a random process aggravated by nutritional and environmental 
lifestyle factors; others argue it is part of a process to eliminate chromosomal 
abnormalities or defective mitochondrial genomes (Pepling, 2006).





































































































The end of female fecundity occurs years before menopause and it is defined as 
the oldest possible age to conceive. The age at the birth of the last child has been 
estimated to be around 41 years of age in studies within natural fertile populations 
in which contraception is not used (O’Connor et al., 1998; Eijkemans et al., 2014). 
There is no clinical symptom alerting women of the end of their reproductive 
lifespan, which is why menopause might be mistaken for the end of fecundity, since 
menopause is a clear event, although defined retrospectively. 
Menopause is the permanent cessation of menstruation resulting from loss 
of ovarian follicular activity (WHO, 1996). A woman is postmenopausal after 
amenorrhea for 12 consecutive months, not caused by other pathological or 
physiological conditions (Soules et al., 2001). The clinical evidence of menopause is 
therefore the final menstrual period. The biological mechanism behind menopause 
is the exhaustion of the follicle pool. It is hypothesized that menopause occurs when 
the population of NGF drops below 1000 (Wallace and Kelsey, 2010) (Figure 2.2). 
The variation in age at menopause has a Gaussian distribution skewed to the left. 
The distribution is similar across different populations (Broekmans et al., 2004), with 
an average of 50 years of age (Otero et al., 2010; Gold et al., 2013; Do et al., 2017). 
Heritability of age at menopause is estimated to range from 30 to 85% (Murabito 
et al., 2005), but the rate of follicular atresia, ultimately leading to menopause may 
also depend on many other environmental and lifestyle factors (Noord et al., 1997). 
From an evolutionary perspective, there are various theories with respect to the 
function of menopause. The disposable soma theory hypothesizes that longevity 
has a negative effect on fecundity (Douglas and Dillin, 2013). This hypothesis 
is supported by the fact that animals with short lives and reproductive lifespan 
such as mice, rats and rabbits, have more offspring compared to elephants and 
primates who have long lives and long reproductive lifespans (Bewley, S., Ledger, 
W., Nikolaou, 2009). On the contrary, adaptive theories suggest that menopause is 
a beneficial trait (Williams, 1957), specifically selected by evolutionary processes, 
with the function to support the reproductive success of the children and survival 
of the grandchildren (Lahdenpera et al., 2004), known as the grandmother effect 
theory (Hawkes, 2004)
3. Diminished ovarian reserve
There is no clear consensus in the literature on the definition of diminished 
ovarian reserve (Cohen et al., 2015). In this thesis, we use the term “diminished 
ovarian reserve” to refer to follicle pool size lower than what is normally expected 
for a women of a certain age, as indicated by the green line in figure 2.2. Factors 
associated with diminished ovarian reserve are the described below.
17
13a. AgeConsensus defines general ageing as changes that deviate from the most 
advantageous stage for optimal reproductive capacity (Rowe and Kahn, 1987). These 
changes can be summarized as accumulation of errors from biological activity due 
to imperfect cellular repair, accumulation of tissue damage due to environmental 
and nutritional factors (Kirkwood and Wolff, 1995) or increase of oxidative stress 
caused by dysfunctional mitochondria (Krakauer and Mira, 1999). All cells have 
repair mechanisms to ensure DNA integrity, especially germ cells, which are 
responsible for the propagation of the species through inheritance(Lombard et al., 
2005). Oocytes for example, have checkpoints during meiosis to verify whether 
all chromosomes are properly replicated, separated and attached to the spindle 
to be equally distributed to the daughter cells. In case of irregularities, cell death 
mechanisms are activated (Aberts et al., 2002). Older oocytes , however, seems to 
continue meiosis, despite irregularities in replication (Marangos et al., 2015). 
One common error is the failure to replace proteins responsible for the 
cohesion between sister chromatids (Mirkovic et al., 2015). After replication, the 
chromosomes, consisting of two chromatids, align in the centre of the cell and are 
attached to spindle fibres via the centromere (see figure 3.1). The spindle pulls 
the sets of chromosomes apart to opposite pools of the cell and with defects in 
cohesion, the daughter cells receive unequal numbers of chromosomes, known as 
aneuploidy (Chiang et al., 2010). 
Figure 3.1: Sister-chromatid cohesion errror and dysfunctional chromosome segregation. 
Source: Díaz-Martínez et al., 2008 Chromosome cohesion- right, knots, orcs and fellowship. 
(Reproduced with permission of the copyright owner)
18
Figure 3.2: Increase in trisomic pregnancy with increasing age and follicle loss.
Footnote: Abbreviation T21: oocytes with three copies of the chromosome 21, DS Down 
Syndrome. Source: (Hultén et al., 2010) The origin of the maternal age effect in trisomy 21 
Down syndrome: The oocyte mosaicism selection model. (Reproduced with permission of the 
copyright owner)
Thus, ageing of the ovaries, or “ovarian ageing”, results not only in the loss of 
quantity, but also in loss of quality in the remaining follicle pool. These two processes 
can occur in parallel, independently of each other, or they can be related. The 
limited pool hypothesis (Warburton, 1989; Kline et al., 2000, 2004, 2011) suggests 
that ageing oocytes are more prone to non-disjunction meiotic errors and, with the 
decrease in quantity of oocytes there is a higher chance of recruitment of those 
oocytes prone to meiotic errors, independent of maternal age (figure 3.2). There 
are other hypotheses attempting to explain a possible association between oocyte 
quantity and quality. The production line hypothesis states that recruitment of 
oocytes for ovulation follows a sequence according to the order of production early 
in life. Oocytes produced later during foetal life are supposed to be of worse quality 
and are recruited last compared to oocytes produced earlier (Polani and Crolla, 
1991). The oocyte mosaicism selection hypothesis states that trisomic oocytes (21, 
for example) accumulate over the years because they are less frequently recruited 
compared to normal oocytes (Hultén et al., 2010).
19
1From a clinical point of view, these errors are observed as difficulties to conceive for women at later ages, a rise in the incidence of offspring with chromosomal aberrations at later ages (Hultén et al., 2010) and increased occurrence of 
miscarriages (LJ, 2004).
3b. Iatrogenic factors: ovarian surgery, radiation, chemotherapy
Apart from ageing, other factors play a role in decreasing the quantity and quality 
of oocytes. In ovarian surgery there is a risk that healthy ovarian tissue is removed 
along with the pathologic specimen supposed to be removed. Specifically in cases 
when parts of the ovarian cortex are removed, NGFs, that reside in the cortex, 
can also be taken (Cagnacci et al., 2016). This mechanical removal of NGFs can 
have a direct effect on the ovarian reserve, and could theoretically lead to earlier 
menopause. Based on current knowledge of follicular atresia, women with unilateral 
oophorectomy would be estimated to reach menopause five to ten years earlier than 
women with both ovaries (Faddy and Gosden, 1996). However, this estimation does 
not correspond to observations. Women with unilateral oophorectomy do reach 
menopause earlier, but the difference is much smaller; it is only of approximately 
one year (Bjelland et al., 2014). If this reduction in quantity is associated with a 
reduction in quality of the remaining oocytes, women with diminished ovarian 
reserve due to surgery would also have an increased risk for miscarriage or trisomic 
pregnancies (Kline et al., 2000).
Chemotherapeutic drugs, especially alkylating agents such as cyclophosphamide, 
are well-known for their deleterious effects on oocytes (Larsen et al., 2003). There 
is a direct association between the dose of antineoplastic agents and follicle loss 
(Morgan et al., 2012), with consequences varying from temporary or permanent 
amenorrhea to premature ovarian insufficiency (Gracia et al., 2012), depending 
on the age of the patient when treatment started and ability to recover (Sklar et 
al., 2006). The mechanism by which chemotherapeutic agents promote follicular 
atresia is not fully understood, but an increased production of reactive oxygen 
species might be involved (Jeelani et al., 2017). 
Radiotherapy, especially when it involves direct radiation of the pelvic region, can 
be even more damaging to ovarian tissue than chemotherapy because radiation is 
particularly toxic to oocytes (Wallace et al., 2005). The risk of radiotherapy-induced 
ovarian failure is around 98%, depending on dose and age of the patient (Wallace 
et al., 2003).
20
3c. Lifestyle factors: cigarette smoking
In the last decades, smoking habits in Europe have been decreasing. In the UK, 
it decreased from 46% of smokers in the 70’s to 20% in 2014 (Figure 3.1 (Office 
for National Statistics, 2016)). Female smoking has been reported to be 17% and 
smoking prevalence during pregnancy is around 11% (Office for National Statistics, 
2016). In the Netherlands, there is a higher percentage of smokers (25% of smokers), 
no gender difference between current male or female smokers in 2014 (WHO 
and Epidemic, 2015) and,  around 13% of Dutch women smoke during pregnancy 
(Gissler et al., 2010).
Figure 3.1: Adult current smokers in Great Britain over the decades
Footnote: In the y-axis, the percentage of smokers and in the x-axis, the decades. Source: 
Health and Social Care Information Centre, Statistics on Smoking, England 2016
Active cigarette smoking is a well-known cause of decreased female reproductive 
function. It is associated with lower fecundity rates, adverse reproductive outcomes, 
such as low birth weight, small for gestational age foetuses, prematurity, intrauterine 
deaths (Cnattingius et al., 1993) and higher rates of IVF failure. All reproductive 
stages and function of reproductive organs are targets of the toxins from cigarette 
smoke, i.e., folliculogenesis, steroidogenesis (impairment of oestrogen synthesis), 
tubal function, embryo transport, later implantation and myometrial activity 
(Dechanet et al., 2011). The suggested mechanism by which cigarette smoking 
impairs fecundity in the ovary involves follicle loss via apoptosis induced by 
polycyclic aromatic hydrocarbons (PAHs) found in cigarette smoke (Borman et al., 
2000; Tuttle et al., 2009). 
21
1Women who are not smokers themselves, but who are exposed to cigarette smoke are called passive smokers. Passive smoking is also known for having a negative effect on women’s reproductive health (Hyland et al., 2016), depending on the level 
and duration of exposure (Taylor et al., 2014). 
In-utero cigarette smoke exposure is a specific way of passive smoke exposure for the 
foetus. Female mice exposed to cigarette smoke in-utero showed reduce germ cells 
numbers at birth (Camlin et al., 2016) and women who were exposed to cigarette 
smoke in-utero may have altered hormone levels, altered age at menarche and 
altered age at menopause (Strohsnitter et al., 2008; Ernst et al., 2012; Gollenberg et 
al., 2015). It is less known, however, whether in-utero exposure to cigarette smoke 
is also associated with decreased fecundity due to decreased follicle quantity or 
quality.
The foetal and infant origins of adult disease theory, proposed by David Barker, 
suggests that the intrauterine environment has a causal relationship with the 
origins of diseases that will manifest later in adult life (Barker, 1990). As previously 
explained, reproductive programming in females is established during the 
embryonic and foetal period (Grive and Freiman, 2015; Kermack et al., 2015) and is 
susceptible to harmful agents such as cigarette smoking by the mother (Dechanet 
et al., 2011; Fowler et al., 2014; Camlin et al., 2016). Based on Barker’s hypothesis 
and on the known effect of cigarette smoking on fecundity for active and passive 
smokers, in-utero cigarette smoke exposure by the smoking of the mother while 
pregnant is very likely to compromise the reproductive health of the unborn child 
in the long-term.
4. Measurement of ovarian reserve
Differently from clinical features of ageing skin, in which loss of collagen is noticed 
by increasing wrinkling in quite evident spots like the face, the decrease in follicle 
pool over the years is not easily noticeable. Clearly, chronological age is a good 
proxy, but there is a large variability of the decline in ovarian reserve with age (Te 
Velde and Pearson, 2002). Therefore age alone is not precise enough. Up till now, 
it is not possible to directly measure the population of NGFs, but some tests have 
been developed to estimate ovarian reserve indirectly.
4a. Ovarian reserve tests (ORTs)
Basal follicle stimulating hormone (FSH) and oestradiol measured in the early 
follicular phase of the menstrual cycle, inhibin B, antral follicle count (AFC), anti-
22
Müllerian hormone (AMH) and ovarian volume are some of the most widely used 
ORTs. The AFC and serum levels of AMH have been demonstrated to correlate 
with ovarian reserve (Hansen et al., 2011) and with the decrease in follicle pool 
with age (Gougeon, 1994). AMH has even been described to predict a woman´s 
age at menopause better than her mother’s age at menopause (Dolleman et al., 
2014). However, ORT models to predict the probability of pregnancy are not precise 
(Hvidman et al., 2016) and have modest-to-poor predictive properties for clinical 
outcomes, such as trisomic pregnancies or miscarriage (Broekmans et al., 2006; 
Rooij et al., 2008). This may indicate that ORTs are primarily associated with the 
quantitative dimension of ovarian ageing, and less with the qualitative dimension. 
This may also explain why prediction of adverse reproductive outcomes with ORTs 
is not possible yet. Nevertheless, ovarian reserve tests are specifically useful in ART 
treatments. The ORTs that have been suggested to improve prediction of ovarian 
response to controlled ovarian stimulation in addition to chronological age are AFC 
(Klinkert et al., 2005) and AMH (Arce et al., 2013).
4b. Controlled ovarian stimulation in IVF treatment
Controlled ovarian stimulation, to which the response can be predicted by ORTs, 
is the basis of ART, and the number of oocytes retrieved to be fertilized in vitro its 
final result. When in-vitro fertilization (IVF) was introduced, the natural follicular 
growth made retrieval of the one oocyte extremely complicated and ineffective 
(Steptoe and Edwards, 1978). Controlled ovarian stimulation was the solution to 
boost oocyte yield by stimulating multiple follicles and inducing ovulation to mature 
multiple oocytes for retrieval and improve chances of pregnancy (Macklon et al., 
2006). Provided that an adequate dosage of gonadotropins is used, the ovarian 
response to controlled ovarian stimulation with gonadotropins is largely determined 
by the ovarian reserve and less so by the type of stimulation protocol (Homburg, 
2014). Hence, the number of retrieved oocytes in IVF procedures can be taken as 
proxy for the ovarian reserve of a woman. 
4c. Response after controlled ovarian stimulation in IVF 
treatment 
Adequate ovarian response, i.e., higher number of retrieved oocytes, in women 
undergoing IVF/ICSI with controlled ovarian stimulation, is associated with higher 
live birth rates, also after age is taken into account (Sunkara et al., 2011). The 
opposite occurs when less oocytes are retrieved (Drakopoulos et al., 2016). Patients 
with a risk of low oocyte yield, i.e., three or less oocytes retrieved in IVF, have been 
identified as a group with poorer outcome, such as lower birth rates, compared 
23
1with patients with a normal response (Polyzos et al., 2012). It is unclear whether low oocyte yield results from an abnormal atresia rate of the follicle pool, or from a lower follicle pool at birth or whether it can just occur as a normal variation in 
the population (Pfeifer et al., 2015). In some cases, a low oocyte yield may be the 
result of underdosage of gonadotropins during ovarian stimulation or it may be a 
random event, despite adequate dosing. A “poor responder” is a women who has 
a consistent low oocyte yield, irrespective of dosage or protocol (Pandian et al., 
2010). The Bologna criteria helps to differentiate women with low oocyte yield in 
one cycle from women who are “poor responders” (Ferraretti et al., 2011). Poor 
responders fulfilling the Bologna criteria are considered to have diminished ovarian 
reserve. The Bologna criteria define poor responders as women who had low oocyte 
yield in two cycles, either cancelled cycles or cycles with ≤ 3 oocytes under optimum 
ovarian stimulation. In addition, women with at least two out of the three features 
are also considered poor responders: (i) maternal age ≥ 40 years, (ii) a previous low 
oocyte yield (cycles cancelled or ≤ 3 oocytes) and (iii) abnormal ovarian reserve test 
(AMH< 0.10 and AFC<7).
Poor responders seems to invariably have poor outcomes after IVF treatment 
(Marca et al., 2015). Therefore, a low oocyte yield can also be seen as a reflection 
of diminished ovarian reserve and might be associated with adverse reproductive 
outcomes in case the quality of the remaining oocytes is associated with quantity. 
Evidence on the association between quantity and quality of oocytes, if true, might 
then be better observed in poor responders than in women with a low oocyte yield, 
which may be the result of random variation. 
5. Adverse reproductive outcomes
5a .Miscarriage
Miscarriage is defined as a clinically recognized pregnancy loss before 20 weeks of 
gestation (Regan and Rai, 2000). It is suggested that 80% of all fertilized oocytes are 
lost during non-specific vaginal bleedings, before pregnancy is clinically recognized 
(Rushton et al., 1975). The overall incidence of miscarriage in clinically recognized 
pregnancies ranges from 8-30% (Wang et al., 2003) but the incidence decreases 
with increasing gestational age and increases with increasing maternal age (Wyatt 
et al., 2005). Age is the most important risk factors for miscarriage (see figure 5.1), 
resulting from maternal age-specific aneuploidies (Benn, 2016). Other known risk 
factors for miscarriage are previous miscarriage, maternal smoking (Regan et al., 
1989; Nybo Andersen et al., 2000; Nielsen et al., 2006), alcohol (Avalos et al., 2014) 
drug-use (Reardon and Ney, 2000), high intake of caffeine (Savitz et al., 2008) and 
24
very low or very high BMI (Veleva et al., 2008; Metwally et al., 2010).
A small percentage of women, around 2%, experience more than one consecutive 
miscarriage (Salat-Baroux, 1988). There is no consensus on the definition of recurrent 
miscarriage, with different options on whether it requires two or three consecutive 
episodes (Sheiner et al., 2005; Rai and Regan, 2006; Committee and Society, 2013) 
and the cause remains obscure for most patients. Some known causes of recurrent 
miscarriages include chromosomal anomalies, maternal thrombophilic disorders 
and congenital structural uterine disorders (Jauniaux et al., 2006).
Miscarriage risk is first and foremost related to chromosomal abnormalities of 
embryos as a consequence of aneuploidy in the female gametes (Eichenlaub-Ritter, 
2012). As such, it can be regarded as a marker of low quality of ovarian reserve. 
If there is an association between quality and quantity of the oocytes, it could be 
expected that apart from ageing, other conditions of diminished ovarian reserve, like 
ovarian surgery or in-utero smoke exposure, may be associated with miscarriage.
Figure 5.1 Risk of miscarriage according to maternal age 
Footnote: The proportion of spontaneous abortions are on the y-axis and female age at 
conception on the x-axis. Source: Nybo Andersen et al., British Medical Journal 2000;320:1708-
1712. (Reproduced with permission of the copyright owner)
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1b. Trisomic pregnancy In the previous section it has been described that a large proportion of fertilized 
oocytes are genetically abnormal and end up in miscarriage (Fritz et al., 2001), 
either clinically detected or not. However, some chromosomal abnormalities 
that do not result in early pregnancy loss may result in a live birth and may be 
viable after birth (Kuliev et al., 2005). The most common numerical chromosomal 
abnormalities are trisomy 21 (Down Syndrome), trisomy 18 (Edwards syndrome) 
and trisomy 13 (Patau syndrome)(Hassold et al., 1996). These are maternal-age 
related aneuploidies and result from errors in chromosome segregation during 
meiosis (Eichenlaub-Ritter, 1996), which become more common with advanced 
maternal age (Hunt and Hassold, 2010; Eichenlaub-Ritter, 2012). Prenatal screening 
during first trimester can diagnose these aneuploidies (Kuliev and Verlinsky, 2004) 
or when not available, diagnosis is determine at birth by recognition of phenotypic 
dysmorphic features present in the new born.
Maternal age is the main risk factor for trisomic pregnancies (see figure 5.2). Since 
trisomy is a marker of low oocyte quality, one can hypothesize that conditions in 
which the ovarian reserve is diminished, could lead to a higher risk of trisomic 
pregnancies.
Figure 5.2: Fertility and miscarriage rates as a function of maternal age
Footnote: The proportion of trisomic pregnancies are on the y-axis and female age at 
conception on the x-axis. Source: Hassold and Hunt, Nature Reviews Genetics 2001; 2:280-
291. (Reproduced with permission of the copyright owner)
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6. Hypothesis 
Based on the assumption that the number of oocytes (ovarian reserve) is related to 
oocyte quality, we hypothesized that diminished ovarian reserve is associated with 
lower quality of the remaining oocytes, leading to an increased risk of miscarriage 
and trisomy. 
In this thesis, ovarian surgery, low oocyte yield after controlled ovarian stimulation 
and in-utero cigarette smoke exposure are taken as proxy for diminished ovarian 
reserve. Trisomic pregnancy and miscarriage are taken a proxy for the quality of the 
ovarian reserve.
Additionally, we hypothesized that diminished ovarian reserve early in life, 
as consequence of in-utero smoke exposure is associated with earlier age at 
menopause.     
7. Aim of the thesis 
The aim of this thesis is to determine whether there is an association between 
diminished ovarian reserve and adverse reproductive outcomes or reproductive 
lifespan (menopause). The association between quantity and quality of oocytes is 
important to be established since women are trying to conceive at a later age, when 
the ovarian reserve is diminished to a level in which there are higher chances of 
adverse reproductive outcomes. The risks of the most common adverse pregnancy 
outcomes, likely to occur in women who postpone childbearing were tested in the 
general and IVF-treated populations. 
8. Outline of the thesis
This thesis focuses on the association between diminished ovarian reserve and the 
quality of the remaining oocytes. The following conditions are taken as a proxy for 
diminished ovarian reserve (a) follicle loss due to ovarian surgery, (b) low oocyte 
yield after controlled ovarian stimulation in IVF treatment and (c) in-utero cigarette 
smoke exposed unborn daughters. The adverse reproductive outcomes explored 
are (a) risk of having a trisomic pregnancy, (b) risk of having a miscarriage, and the 
reproductive lifespan as (c) risk of reaching menopause earlier. An overview of the 
chapters in this thesis is given below (see figure 8.1)
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1Figure 8.1: Graphical depiction of the association between potential diminished ovarian reserve conditions and the adverse reproductive outcomes studied in this thesis.
28
9. Overview of chapters
Chapter 2 is a case-control study within a Danish national registry on the association 
between trisomic pregnancy, as a marker of decreased oocyte quality and ovarian 
surgery as a proxy for diminished ovarian reserve 
Chapter 3 is also a case-control study including women who had IVF treatment. 
This study included Danish and Dutch patients. The study tested the association 
between low oocyte yield after controlled ovarian stimulation and the risk of a 
trisomic pregnancy. 
Chapter 4 is a cohort study including Dutch women who had IVF treatment. 
The study tested he hypothesis whether a repeated low oocyte yield during IVF 
treatment is associated with a higher risk of having a miscarriage
Chapter 5 investigated whether women who were exposed to cigarette smoke 
have a higher chance of having a miscarriage compared to women who were not 
exposed. It included participants of a longitudinal study from UK.
Chapter 6 also included women who are participants of a longitudinal study in 
the UK and investigated whether women who were in-utero exposed to cigarette 
smoke have higher changes of earlier menopause compared to women who were 
not in-utero exposed.
Chapter 7 provides a summary of results, general discussion of the finding from 
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Abstract
Study question: Is there an association between trisomic pregnancy, a marker for 
decreased oocyte quality, and the reduced oocyte quantity that follows ovarian 
surgery?
Summary answer: Previous ovarian surgery is not associated with an increased risk 
for a subsequent trisomic pregnancy.
What is known already: Ovarian surgery diminishes the number of oocytes. The risk 
for a trisomic pregnancy is suggested to be higher in women with fewer oocytes, 
independent of their chronological age.
Study design, size, duration: This is a matched case-control study. Cases are women 
with a confirmed trisomic pregnancy occurring between January 1st 2000 and 
December 31st 2010 regardless of pregnancy outcome and controls are women 
that had a live born child without a trisomy. In total there were 8573 participants in 
the study; 1723 cases and 6850 controls.
Participants/materials, setting, methods: Data were obtained from Danish medical 
registries. Matching criteria were maternal age and year of conception. Number 
of controls matched per case ranged from 1 to 4. Among cases and controls with a 
trisomic pregnancy, 2.7% (46/1723) versus 2.5% (172/6850) had undergone ovarian 
surgery before pregnancy.
 Main results and role of chance: History of ovarian surgery is not associated with 
a higher risk for a subsequent trisomic pregnancy (odds ratio=1.00, 95%confidence 
interval 0.99-1.01). Subgroup analyses by indication of surgery and interval between 
ovarian surgery and pregnancy do not show an effect on trisomic pregnancy risk. 
Limitations, reasons for caution: The medical registries used to select cases and 
controls did not contain information on surgical technique nor volume of ovarian 
tissue resected, previous trisomic pregnancy prior to the ovarian surgery or long-
term use of oral contraceptives. Therefore, correction for these factors was not 
performed. 
Wider implications of the findings: We did not confirm the hypothesis that ovarian 
surgery, a marker for decreased oocyte quantity, is related to trisomic pregnancy, a 
marker for decreased oocyte quality. This suggests that ovarian surgery, which has 
a direct reductive effect on the size of the follicle pool, may affect oocyte quality 
differently when compared to the reduction in follicle pool size due to ageing.
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Aneuploidy is the main cause of congenital birth defects and miscarriage(Hassold 
et al., 1996; Fritz et al., 2001; Boyd et al., 2011). The most common autosomal 
chromosomal aberrations are trisomy 13, 18 and 21 (Irving et al., 2011; Loane 
et al., 2013), which result from errors during meiosis. Maternal age is known as 
the major factor influencing the rate of meiotic errors, specifically meiotic non-
disjunction (Hook, 1981; Fisch et al., 2003; Pellestor et al., 2003). The underlying 
mechanism of meiotic non-disjunction associated with ageing is unknown but 
multiple causal factors resulting in loss of sister chromatid cohesion, accumulation 
of environmental damage, hormonal change or a smaller oocyte pool (Nagaoka et 
al., 2012)are thought to be involved.
It is indisputable that the number of antral follicles available for maturation 
decreases with ovarian aging (Faddy and Gosden, 1996); the number of oocytes 
steadily decreases by ovulation, atresia and apoptosis (Baker, 1963) and menopause 
occurs when the number drops below a critical value (Faddy and Gosden, 1996).
The link between ovarian ageing and increased rates of aneuploid oocytes is 
explained by the so called oocyte pool hypothesis, which states that with a lower 
number of oocytes a selection of suboptimal oocytes for ovulation occurs more 
frequently, resulting in higher risk of aneuploidy (Warburton, 1989). According to 
this hypothesis, pregnancy outcome is better predicted by ovarian age parameters, 
irrespective of the chronological age. Indeed, increased risk for a trisomic pregnancy 
in cases of fewer oocytes, independent of chronological age, has been described 
before (Brook et al., 1984).
Not only physiological ageing decreases follicle numbers, but also iatrogenic damage 
such as ovarian surgery (Garcia-Velasco and Somigliana, 2009; Benaglia et al., 2010; 
Berlanda et al., 2013) leads to a smaller follicle pool. In a small study, women with 
surgical removal of one of their ovaries were more likely to have a child with Down 
syndrome later in life when compared to non-operated controls (Freeman et al., 
2000). Our research group has previously found an association between trisomic 
pregnancy and history of ovarian surgery prior to pregnancy in subfertile women 
treated with IVF (Haadsma et al., 2010b). However, the results of this latter study 
cannot be generalized to the fertile population. 
Therefore, the aim of our present study is to determine the effect of ovarian surgery 
on the risk for a subsequent trisomic pregnancy based on general population data 
with a large sample size. The hypothesis is being tested at population level, that 
is, it includes normal fertile women with spontaneous pregnancies, as well as 
infertile women pregnant via assisted reproductive techniques (ART). In this study, 
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trisomy is taken as a parameter for oocyte quality, that is, an underlying parameter 
of nondisjunction, and ovarian surgery as a model for reduced oocyte quantity or 
reduced size of follicle pool and we expect these two parameters to be positively 
correlated (less quantity indicating less quality) independent of chronological 
age. We hypothesized that women who have undergone ovarian surgery have an 
increased risk for a trisomic pregnancy later in life. 
Material and Methods
Study design and participants
We performed a matched case-control study based on data from nationwide Danish 
medical registries. All women with a confirmed trisomic pregnancy between January 
1st 2000 and December 31st 2010 registered at the Hospital Discharge Register and 
at the Cytogenetic Central Register were selected as cases. We excluded trisomic 
pregnancies of women born in Greenland and Faroe Islands or any countries 
outside Denmark. Trisomies 13, 18 and 21 confirmed by karyotyping were included, 
regardless of the pregnancy outcome (termination, intra-uterine death, still-born 
or live-born child) to avoid underestimation of the risk. Trisomic pregnancies with 
translocations as the underlying mechanism or pregnancies with oocyte donation 
were excluded. Controls were women who had a live born child without a trisomy 
in the same birth period as cases. Cases and controls were selected irrespective of 
surgery status. Matching criteria were maternal age and year of conception. The 
indication of ovarian surgery in cases and controls was derived from ICD-10 codes 
(International classification of diseases, 10th revision). Those included: malignancies 
of the female genital tract (DC53.0-57.9); benign neoplasm of ovary (DD27.0-27.9); 
benign neoplasm of other and unspecified female genital organs (DD28.0-28.9); 
neoplasm of uncertain or unknown behavior of female genital organs (DD39.0-
39.9); polycystic ovary syndrome (PCOS) (DE28.2); salpingitis and oophoritis (DN 
70.0-70.9) other female pelvic inflammatory diseases (DN73.0-73.9); endometriosis 
(DN80.0-80.9); non-inflammatory disorders of the ovary, Fallopian tube and broad 
ligament (DN83.0-83.9); extra-uterine pregnancy (DO00.0-00.9)
Statistical methods
Descriptive statistics were used to compare differences between cases and 
controls and to test whether they were matched adequately. In order to test the 
hypothesis that women with a history of ovarian surgery have an increased risk for 
having a trisomic pregnancy, analyses were performed with Generalized Estimating 
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Equations (GEE), assuming a fixed non-zero correlation within clusters consisting of 
cases and their matched controls (exchangeable correlation structure). Subgroup 
analyses were performed to assess the risk of trisomic pregnancy depending on 
the indication that led to surgery and the influence of the interval between ovarian 
surgery and pregnancy. Intervals below the 25th percentile were categorized as 
short interval; intervals above the 75th percentile were categorized as large interval. 
Intervals in between the 25th percentile and the 75th percentile were categorized 
as intermediate. The categorization was conducted to determine whether surgery 
would affect ovary function particularly just after surgery (short interval) or whether 
the negative effects of surgery would appear only later in time. Stratified analyses 
for different age groups were made by categorizing age in the following percentiles: 
below 25th percentile, above 75th percentile and the interval in between percentile 25th 
and 75th. The relationship between intervals and probability of trisomic pregnancy 
was explored by spline regression using Stata LC version 11 (Supplier: Statacorp. 
College Station, Texas, USA). The probability of having a trisomic pregnancy was 
calculated for each of the interval time points between surgery and pregnancy. 
A figure was created to visualize the curve of probability when connecting all the 
interval time points. A P-value of less than 0.05 was considered significant. Analyses 
were performed using the IBM Statistical Package for the Social Sciences software, 
version 20 (Supplier: IBM Corporation. Armonk, NY, USA). 
Results
Table I shows characteristics of cases and controls in the study. In total, 8573 
women were included in our study. Controls were 6850 and cases 1724; 1 case 
could not be matched to controls, 12 controls didn’t have a match, 1679 cases were 
matched with 4 controls, 40 cases with 3 controls, 2 cases with 2 controls and 1 
case with 1 control. Among the trisomic pregnancies 7.5% (129/1723) were trisomy 
13 cases, 19.7% (340/1723) were trisomy 18 cases and 72.8% (1254/1723) were 
trisomy 21 cases. There were 278 live born trisomic pregnancies (16.1%) and 1445 
(83.9%) terminations, intra-uterine deaths/stillborn. The average (± SD) maternal 
age at conception was 34.5 years (±5.4), ranging from 16 to 47 years and there 
was no significant difference in the average age between cases and controls. There 
were 218 women with a history of ovarian surgery before pregnancy. Among these, 
9 women had a biopsy, 82 had an excision of pathological tissue in the ovary, 77 
had an ovarian resection, 15 had an ovarian excision, 30 had an excision of ovary 
and a salpinx. The main file with the medical registries included all women that 
had ovarian surgery. There was a pathology file with information about the type 
of ovarian surgery women had. Information on the type of ovarian surgery was 
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missing for five women. Women who did not have ovarian surgery and women who 
had ovarian surgery after pregnancy were included in the reference group labelled 
“no surgery”. The average age at surgery was 28.4 years (±6.46), ranging from 
13.7-43.5 years and the difference of 1 year between cases and controls was not 
significant. The three most prevalent indications for surgery were benign neoplasm, 
endometriosis and non-inflammatory disorders. The mean interval between ovarian 
surgery and the subsequent pregnancy was 7.82 years; 25th and 75th percentiles 
were 2.20 and 12.92 years, respectively. Interval range for cases varied from 0.15-
20.61 years; for controls from 0.05-27.75 years and controls had on average a 1.3 
years longer interval when compared to cases. The majority of women included in 
this study conceived spontaneously, but intrauterine insemination (IUI) and ART 
were also observed (see Table I). Cases and controls differed significantly by mode 
of conception and interval between surgery and pregnancy. Results did not change 
when sensitivity analyses were performed by restricting the analyses to trisomy 21 
cases and their controls, or when selecting only spontaneous pregnancies. 
Table II shows results for the comparison between women who underwent ovarian 
surgery before pregnancy and women who did not. Overall, there was a 1.1% 
difference in proportions for trisomic pregnancies between groups. A history of 
ovarian surgery was not statistically significantly associated with a higher risk for 
a subsequent trisomic pregnancy. Subgroup analyses with the selection of women 
who had surgery due to benign neoplasm, endometriosis or non-inflammatory 
disorders did not change the results. Neither a short interval between surgery and 
pregnancy nor a longer interval had an effect on the risk for a trisomic pregnancy 
when compared to the reference group. 
When we stratified for groups of younger than 31 years, older than 39 years and 
between 32 and 39 years of age (percentiles 25th, 75th and in between 25th and 
75th ) the results did not change. We have performed additional sensitivity analyses 
regarding interval between surgery and pregnancy. Results did not change when 
excluding the large interval or when excluding the short interval group. Adjusting 
for mode of conception and age at surgery also showed no difference between 
groups. 
There was a trend indicating that the shorter the interval between ovarian surgery 
and pregnancy, the higher the probability for a trisomic pregnancy, but no significant 

































































































































































































































































































































































































































































































































































































































































































































































































Table II: Odds ratio for the trisomic pregnancy associated with ovarian surgery
Footnote: one case was not matched
Total OR and 95% CI for the risk
N=8573 of trisomic pregnancy
No surgery  8355 *reference group
Ovarian surgery 218 1.001 [0.988-1.014]
Indication of ovarian surgery
Benign neoplasm 70 0.993 [0.971-1.016]
Endometriosis 45 1.018 [0.991-1.045]
Non-inflammatory disorders 54 0.992 [0.961-1.025]
Interval between surgery and pregnancy
Short interval (<P25th)1 54 1.019 [0.981-1.039]
Intermediate interval (p25th-p 75th) 109 0.999 [ 0.981-1.017]
Large interval (>P75th) 54 0.997 [0.972-1.021]
Discussion
A history of ovarian surgery was not associated with a higher risk of a subsequent 
trisomic pregnancy, independent of the indication of surgery or the interval between 
ovarian surgery and pregnancy. 
Animal studies support the hypothesis that ovarian surgery may have an effect on 
oocyte quantity and quality. Female mice had an earlier and increased incidence of 
aneuploid embryos after unilateral ovariectomy (Brook et al., 1984). Nevertheless, 
evidence in women is conflicting. A previous study (n=4795) looking at the relation 
between ovariectomy and trisomic pregnancy resulting in spontaneous abortion 
found no effect of surgery [odds ratio (OR)=1.5, 95% confidence interval (CI) [0.4-
3.9]) (Kline et al., 2000). Levels of anti-mullerian hormone (AMH), FSH and inhibin 
B or sonographic antral follicle count (AFC), all parameters of the size of the follicle 
pool, were not statistically associated with trisomic losses in some studies (Kline 
et al., 2004; Grande et al., 2014), while in other studies, women with trisomic 
pregnancies showed evidence for depletion of the follicle pool as indicated by 
elevated FSH levels (van Montfrans et al., 1999, 2002). All of these previously cited 
studies as well as this current study are based on the same underlying mechanism: 
indicators of ovarian follicle pool size and their association to aneuploidy rates, 
irrespective of chronological age. 
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Figure I: The probability for a trisomic pregnancy in women according to interval between 
ovarian surgery and pregnancy
Footnote: Spline regression is a technique to investigate non-linear relationships between 
a determinant and an outcome. We used restricted cubic spline regression, which means 
that the probability of having a trisomic pregnancy was calculated for multiple intervals 
between surgery and pregnancy. The regression lines for each interval were connected with 
smoothed transitions, resulting in a curve visually representing the probability of trisomy 
as a function of interval between surgery and pregnancy.The dots at the top represent time 
intervals for cases and the dots below for the controls. The middle dot is a case and control 
with the same time interval. The continuous line is the expected probability and the dark 
area, the 95% confidence interval. There was a trend suggesting that the shorter the interval 
between ovarian surgery and pregnancy, the higher the probability for a trisomic pregnancy, 
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Strengths of the current study are the sample size and the majority of clusters 
having four controls per case, as well as inclusion of all pregnancies irrespective of 
outcome (termination, intra-uterine death, still born or live born child) and different 
modes of conception (spontaneous, IUI or different ART methods). The selection 
of more than four controls per case would have minimal effect on statistical power 
(Rothman, 1986). The statistical method of our choice (GEE) enabled good estimates 
of ORs, expressed in small CIs, that is, a more accurate estimate. Additionally, the 
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method accounts for dependency of the matching between case and controls. 
This explains the risk of 1.02 for trisomy for the group that had surgery due to 
endometriosis even though the differences in proportions were 10.2% between 
cases and controls. In all analyses, despite the absence of differences in p-values 
among statistical methods, the risk was higher when using an independent type of 
analysis (e.g. logistic regression), but this effect was diminished when taking into 
account the clustering and the dependent matching structure.
The medical registries used to select cases and controls have limitations, for example 
they did not contain information on surgical technique or volume of ovarian tissue 
resected, for which we could not control in the analyses. Nevertheless, the indication 
of surgery can be regarded as a predictor of the amount of tissue necessary to be 
resected. Surgical techniques such as cystectomy are usually minimally invasive, 
whereas resection of endometriomas generally requires a far greater amount of 
tissue to be removed. In our study, the indications of surgery and the most prevalent 
ICD codes that required more tissue to be removed (endometriosis (DN80.0-80.9)) 
did have a higher proportion of trisomic cases compared to the indications that 
needed less tissue removed, but the difference was not statistically significant. It 
has been argued that different surgery procedures have different effects on ovarian 
volume and the oocyte pool (Var et al., 2011). Moreover, other confounding factors, 
such as previous trisomic pregnancy prior to ovarian surgery and subsequent 
pregnancy (Souza et al., 2009) or long-term use of contraceptives in the period 
between surgery and pregnancy, that could have an effect on the quantity of 
oocytes (Nagy et al., 2013) could not be corrected for.
Women who have undergone ovarian surgery before pregnancy represented 2.57% 
(220/8573) of the total study population. One can argue that comparison groups 
are not proportional in the number of participants, nevertheless, case-control 
studies should not include subjects based on exposure (in this study, surgery prior 
to pregnancy) and ovarian surgery is a rather uncommon event. Therefore, the 
population at risk was impossible to predict due to study design. 
Our present results do not confirm the findings from two other studies on this 
subject. One previous case-control study, including a small number of women that 
underwent ovarian surgery (7 cases and 1 control), reported an OR of 9.61 (95% 
CI 1.18-446.3) for trisomic pregnancy in women who have undergone previous 
ovarian surgery; that is surgical removal of all or part of the ovary or congenital 
absence of one ovary (Freeman et al., 2000). The sample size of the previous study 
(Freeman et al., 2000) was small, hence possibly an overestimation of the effect 
size was shown. Our study with a robust sample size does not confirm these results. 
40
Our research group has previously found, in subfertile women who had undergone 
IVF, an association between trisomic pregnancy and a history of ovarian surgery 
prior to pregnancy (OR=3.3 95% CI [1.0-10.5]) (Haadsma et al., 2010b). We did not 
find similar results in the present study, in which we have analysed the data within 
a general population, and not only in subfertile women who had undergone IVF. 
Appropriate analyses with only IVF women in this study were not possible because 
the matching structure would be lost.
Our results may be explained by the hypothesis that the natural reduction of 
ovarian reserve by aging and the iatrogenic effect of surgery could represent 
different mechanisms of depletion of the oocyte pool. In a meta-analyses, AMH 
levels decreased by 40% (-1.13 ng/ml; 95% CI -0.37 to – 1.88) after excision of 
ovarian endometriomas; the effect was still present in studies in which age was 
not a significant confounder (age≤ 40 years), but no effect of surgery was found 
for AFC (Raffi et al., 2012). Furthermore, there may also be a compensatory effect 
of the non-operated ovary on total ovarian function over time. Women who had 
gone through unilateral oophorectomy had more follicles and oocytes at time of 
IVF stimulation than the ipsilateral ovary of women with both ovaries, suggesting a 
compensatory follicular recruitment of the remaining ovary (Khan et al., 2014). The 
previous study (Khan et al., 2014) does not consider the interval between surgery 
and IVF treatment, but, if there is a time effect for recovery of the remaining ovary, 
then the highest risk for a trisomic pregnancy would be expected to be within the 
short interval between surgery and pregnancy. An effect of surgery only in the short 
interval could mean that the non-operated ovary could be compensating as a long-
term response to the lack of tissue in the operated ovary; an effect of surgery only 
in the long interval could mean that the compensating function of the other ovary 
exhausts over time. Our data show this higher risk for a shorter interval (figure 1), 
although risks did not differ statistically. 
The lowest risk period for a women to have a trisomic pregnancy is not around 
menarche (Hunt and Hassold, 2010) when oocytes are expected to be “young” and 
in great quantity; there is a higher risk for trisomy for pregnancies of 15-year olds 
than for 18-year olds. Additionally, only the quantity may not be enough either; 
there was no fertile window extended for women with PCOS in a recently published 
study (Kalra et al., 2013). The quantity of oocytes for the PCOS population was 
higher when compared to women with tubal factor infertility only up to 40 years 
of age, but in older women there was no difference. Moreover, the correlation 
between quality and quantity may not be linear and loss of ovarian tissue could 
become more critical over time as the other remaining follicles ages, but this is not 
what we have found with our age category data analyses. 
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Finally, our study indicates that an intervention, such as ovarian surgery, that has 
a direct reductive effect on the size of the follicle pool, influences the relation of 
oocyte quantity and quality differently compared to the reduction in follicle pool 
size due to ageing. In summary, our findings indicate that ovarian surgery is not 
associated with a higher risk of a subsequent trisomic pregnancy. Women with a 
history of ovarian surgery prior to pregnancy may not be regarded to be at higher 
risk for a trisomic pregnancy. 
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Abstract
A low number of antral follicles may result in the selection of suboptimal oocytes 
that are prone to meiotic errors. The aim of this case-control study was to evaluate 
whether IVF-treated women with low oocyte yield (defined as ≤ 3 oocytes retrieved 
after controlled ovarian stimulation) are at an increased risk of a trisomic pregnancy. 
Data were obtained from Danish and Dutch medical registries between 1983 and 
2011. Analyses were performed in 105 cases and 442 controls matched by age and 
year of IVF treatment. Cases were women with a trisomic pregnancy (trisomies 13, 
18 or 21) resulting from fresh IVF treatment and confirmed by karyotyping. Cases 
were included regardless of pregnancy outcome. Controls were women with a live 
born child without a trisomy, resulting from fresh IVF treatment. Low oocyte yield 
was observed in 6.6% (29/440) of the women, of which 8.4% (7/83) were cases and 
6.2% (22/357) controls. Low oocyte yield in IVF treatment was not associated with 
a higher risk of trisomic pregnancy (OR 1.43, 95% CI 0.64-3.19). Stratification for 
female age, adjustment for history of ovarian surgery, and GnRH protocol used did 
not change the results.
Key words: oocyte; ovarian reserve; trisomy; IVF.
Key message: Our results indicate that a low oocyte yield in response to ovarian 





Female age and the number of retrieved oocytes are important determinants of 
success in in vitro fertilisation (IVF) treatment with controlled ovarian stimulation 
(Sunkara et al., 2011; Oudendijk et al., 2012; Polyzos et al., 2014). In women of 
advanced age, oocytes are more susceptible to meiotic errors leading to aneuploid 
embryos, which increase the risk of trisomic pregnancies (Fragouli et al., 2011; 
Eichenlaub-Ritter, 2012; Harton et al., 2013). Likewise, low oocyte yield, i.e., ≤ 3 
oocytes retrieved after controlled ovarian stimulation in IVF treatment (Ferraretti 
et al., 2011), has been hypothesized to be associated with higher aneuploidy 
rates. Low oocyte yield is often the result of having a low number of antral follicles 
available (Younis et al., 2005). The limited pool hypothesis states that a low number 
of antral follicles results in the selection of suboptimal oocytes that are prone to 
non-disjunction during meiosis (Warburton, 1989). Thus, women with a low oocyte 
yield are hypothesized to have an increased risk of aneuploidy, irrespective of their 
age. 
In a previous study in a Dutch IVF cohort, we could not confirm or reject this 
hypothesis. There was a non-significant increased risk of a trisomic pregnancy for 
women who had ≤ 3 oocytes were retrieved (OR 2.72 96%CI 0.69-10.69) and a 
significant increased risk when ≤ 4 oocytes were retrieved (OR 3.97 95%CI 1.37-
11.51). Although an increased risk was observed for both cut-offs, for the most 
common definition of poor response (≤ 3 oocytes), it was not significant (Haadsma 
et al., 2010b). Additionally, the confidence intervals were quite large, preventing 
a definite conclusion. Therefore, we replicated our study in a different and larger 
cohort of Danish women. In order to increase the generalizability of our results and 
provide an estimation of the association between oocyte yield and trisomy risk, 
we combined the data from the Danish cohort and the Dutch cohort previously 
published. This study aimed to determine whether IVF-treated women with a low 
oocyte yield are indeed at an increased risk of a trisomic pregnancy.
Material and Methods:
Study design
We performed a matched case-control study within a nationwide Danish IVF cohort 
(n=379). Additionally, the Danish cohort was combined with a previously published 
Dutch case-control study within a nationwide cohort (n=168) of IVF-treated women 
(conventional IVF or IVF with intracytoplasmic sperm injection (ICSI)). Therefore this 
study contains analyses of three datasets: the Danish cohort, the Dutch cohort (re-
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analysed with current statistical methods to standardize results) and the Danish and 
Dutch combined cohort.
The Danish cohort
 Data for the Danish cohort were selected from three Danish nationwide registers: 
the Hospital Discharge Register, the IVF Register (paper-based reporting for the 
period of 1999-2005 and electronic reporting for the period of 2006-2010) and 
from the Cytogenetic Central Register. These registries cover all Danish IVF cycles 
since records are compulsory and required by law in Denmark. Women who had 
controlled ovarian hyperstimulation with either human menopausal gonadotropin 
(hMG) or recombinant follicle stimulating hormone (rFSH) were included. Women 
who took clomiphene citrate during their IVF treatment were excluded as were 
women without information on their type of medication. Each woman could 
contribute to the data with one treatment cycle only, independent of the cycle 
number. Pregnancies resulting from frozen embryo transfer or oocyte donation 
were not included. Cases were women with a trisomic pregnancy (trisomies 13, 
18 or 21) resulting from fresh IVF treatment. Trisomic pregnancies were either 
identified after elective prenatal diagnosis or at the identification of ultrasound 
abnormalities, intra-uterine death, still birth or after birth, and confirmed by 
karyotyping. Trisomies caused by a chromosomal translocation were not included, 
since these may result from parental balanced chromosomal translocations rather 
than being associated with maternal age. Cases were included regardless of the 
pregnancy outcome (termination, intra-uterine death, stillbirth or live born child). 
Controls were selected independent of oocyte yield and included women with a live 
born child without a trisomy, resulting from fresh IVF treatment. Matching criteria 
were female age at start of IVF treatment and year of IVF treatment. A maximum 
of four controls were selected for each case, if available after applying matching 
criteria. Data were structured and analysed in clusters, i.e., grouping cases and their 
matched controls, since observations within clusters are correlated and cannot be 
regarded as independent, while observations between clusters are independent 
(Halekoh et al., 2006) . This study was performed with permission from the Danish 
National Board of Health (file number 6-8011-950/1) for the Danish cohort.
The Dutch cohort
The Dutch cohort has been described previously (Haadsma et al., 2010b). Briefly, 
it is a retrospective nationwide cohort study (OMEGA project) of infertile women 
visiting one of the twelve Dutch IVF centres between 1983-1995. Each woman could 
contribute to the data with one treatment cycle only, independent of the cycle 
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number. Cases were women with a trisomic IVF-pregnancy (trisomies 13, 18 and 
21, confirmed by karyotype, excluding translocation-based trisomies) regardless of 
pregnancy outcome (termination, intra-uterine death, stillbirth or live born child). 
Controls were selected independent of oocyte yield and included women with a 
live born child after IVF, without a trisomy. Matching criteria were female age at 
start of the IVF treatment, year of IVF treatment and fertility centre. Each case was 
matched to five controls and data were structured and analysed in clusters. For this 
cohort, two cases resulting from spontaneous pregnancies which occurred within 
one year after the IVF treatment were included along with their matched controls 
to maximize sample size. The number of oocytes from the treatment was taken as a 
proxy of their ovarian reserve status.
The institutional review boards of the participating IVF centres approved the study 
protocol for the Dutch cohort, and all patients gave written informed consent and 
permission to search their medical files.
The Danish and Dutch combined cohort
The Danish and Dutch cohorts were combined and analysed as one cohort. The 
structure of clusters of cases and controls was maintained. The analyses were 
performed stratifying the data by site (Dutch or Danish).
Statistical methods
For the current study, the relationship between oocyte yield and risk of trisomy was 
analysed in three different ways, i.e., with oocyte yield as a continuous outcome, 
as a dichotomous outcome (≤3 as low oocyte yield or ≥ 4 oocytes as normal oocyte 
yield) and with spline regressions. The cut-off of ≤ 3 oocytes was defined as such 
according to current clinical recommendations (Ferraretti et al., 2011). Since the 
defined cut-off value for low oocyte yield may not correlate with the biological 
association between oocyte number and trisomy risk, we also performed restricted 
cubic spline regressions to explore the possibility of a non-linear relation between 
the number of oocytes and trisomy risk. To evaluate whether a low oocyte yield 
increases the risk of having a trisomic pregnancy, we used generalized estimating 
equations (GEE). This statistical method accommodates the nested structure of 
the data, i.e. the clusters of cases and their matched controls, even if cluster size 
varies, and it provides unbiased estimations when missing values are missing at 
random (Little and Rubin, 2002). We assumed a fixed non-zero correlation within 
clusters (exchangeable working correlation matrix), i.e., cases and controls within 
the clusters are not independent due to the grouping by similar characteristics. 
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Subanalyses were performed with factors that could affect the number of oocytes 
including stratification by female age (younger or older than 40 years), adjustment 
for use of a gonadotropin-releasing hormone (GnRH) agonist or antagonist protocol 
and history of ovarian surgery prior to IVF treatment.
Splines were calculated using Stata LC version 11 (Statacorp LP, College Station, 
Texas, USA). SPSS Statistics, version 20, was used for all the other analyses (IBM 
Corporation, Armonk, NY, USA). A p-value of less than 0.05 was considered 
statistically significant. 
Results
The results of the Danish cohort, Dutch cohort and Danish and Dutch combined 
cohort are described below. Table I shows the characteristics of the respective 
cohorts and table II shows the odds ratios (ORs) for a trisomic pregnancy associated 
with oocyte yield. 
Danish cohort
The Danish cohort included a total of 408 women, of which 85 were cases and 
323 matched controls. There was no statistical age difference between cases and 
controls (p-value=0.52), asserting that the matching was successful. Eight cases 
and 21 controls with clomiphene citrate use or missing information on medication 
were excluded, leaving 379 women (77 cases and 302 controls) for analysis. In total, 
53 cases had four controls matched; 17 cases had three controls, five cases had 
two controls and one case had one control. One case and 28 controls were not 
matched after exclusions and these clusters were maintained in our analysis since 
the statistical method accounted for missing values and clusters of different sizes.
The main causes of infertility were male factor (30.9%) and unexplained infertility 
(22.2%). Of all women, 28% (107/379) had an unknown number of oocytes retrieved, 
of which 28.6% (22/77) were cases and 28.1% (85/302) controls. We performed a 
missing values analysis and which showed no specific pattern in the missing values. 
There was no statistical difference between missing data and available data for the 
number of oocytes for age (37.1 versus 36.4 respectively, p=0.15 Mann-Whitney 
U test), ovarian surgery (8.4% versus 10.3% p=0.58, Pearson’s Chi Square test) and 
causes of infertility (male factor p=0.14, unexplained p=0.37, Pearson’s Chi Square 
test) validating the assumption of missing at random. 
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In the Danish cohort, a low oocyte yield was not associated with a higher risk of 
having a trisomic pregnancy after IVF (see table II). Stratification for female age 
younger or older than 40 years did not change the results. Women with a history of 
ovarian surgery before IVF treatment, despite having decreased ovarian volumes, 
did not have a higher risk of a trisomic pregnancy compared to women without 
previous surgery. 
In the Danish dataset, 268 women (55 cases and 213 controls) used a GnRH agonist 
and 66 women (15 cases and 51 controls) a GnRH antagonist. The mean number of 
oocytes retrieved in women who used agonists was significantly higher than in the 
women who used antagonists (9.9 ± 4.6 and 7.4 ± 3.8 respectively, p-value < 0.01), 
but adjusting for the use of either a GnRH agonist or antagonist did not change our 
results (OR 0.99, 95% CI 0.79-1.24). 
The Dutch cohort
The results for the Dutch cohort have been reported previously (Haadsma et al., 
2010b).. Table II shows the main results of the Dutch data re-analysed with current 
statistical methods. There was no statistical association between low oocyte yield 
and trisomic pregnancy. Women with a history of ovarian surgery before IVF 
treatment did not have a higher risk of a trisomic pregnancy. 
Since the Danish cohort included only pregnancies resulting from IVF, sensitivity 
analysis to maximize comparability with the Danish cohort was performed excluding 
the Dutch spontaneous pregnancies (2 cases and their 10 matched controls). Results 
for the risk of miscarriage for low oocyte yield did not change materially (OR 1.02, 
95% CI 0.99-1.05).
The Danish and Dutch combined cohort
In total, 547 women were included in the combined analyses (105 cases and 442 
controls). The number of retrieved oocytes was unknown in 19.6% (107/547) of 
the women. Low oocyte yield in IVF treatment was not associated with the risk of 
a trisomic pregnancy. The results were similar when analyses were stratified for 
female age (younger or older than 40 years). A history of ovarian surgery before 
IVF treatment was not associated with a higher risk of having a trisomic pregnancy. 
Sensitivity analysis excluding the Dutch spontaneous pregnancies (2 cases and their 
10 controls ) did not change the results for the risk of miscarriage for low oocyte 



















































































































































































































































































































































































































































































Table II. Odds Ratio for trisomic pregnancy associated with oocyte yield: Danish cohort, 
Dutch cohort and Danish and Dutch combined cohort.
Footnote: abbreviations: OR odds ratio, CI confidence interval. *Only 15 women with more 
than 40 years of age.
Danish cohort Dutch cohort Danish and Dutch 
combined cohort 
OR, 95% CI OR, 95% CI OR,95% CI
Oocyte yield 1.00, 0.99-1.01 1.00, 0.99-1.00 1.00, 0.97-1.03
Low oocyte yield 
 ≤ 3 oocytes 1.00, 0.97-1.03 1.02, 0.99-1.05 1.43, 0.64-3.19
 ≥ 4 oocytes reference reference Reference
Subanalysis- stratified data
Women < 40 
years
0.99, 0.93-1.06 1.11, 0.81-1.54 1.13, 0.65-1.97
Women ≥ 40 
years
1.28, 0.58-2.83 * 2.16, 0.43-10.8
Ovarian surgery before IVF
  Yes 1.02, 0.88-1.20 1.05, 0.98-1.13 1.47, 0.89-2.44
  No reference reference Reference
Figures I, II and III show spline regressions for the Danish cohort, the Dutch cohort 
and the Danish and Dutch combined cohort. In the Danish cohort a low number 
of oocytes retrieved was not associated with a higher probability of a trisomic 
pregnancy (p = 0.99). Although visual inspection of the spline curves for the Dutch 
and the Danish and Dutch combined cohorts suggested an increased probability 
of a trisomic pregnancy at lower numbers of oocytes retrieved, the non-linear 
association was not statistically significant (p = 0.19 and p = 0.40, respectively). 
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Figure I: Spline regression for the Danish cohort
Footnote: Spline regression is a technique to investigate non-linear relationships between 
a determinant (number of oocytes) and an outcome (risk of trisomy). The figure shows 
restricted cubic spline regression with the probability of having a trisomic pregnancy 
calculated for each of the values of the number of oocytes retrieved (see dots,•) . A dot 
may represent one or more cases or controls. In case of more than one case with the same 
number of oocytes, the average outcome is presented (e.g., 0.25 for cases with one oocyte 
retrieved). The regression line for each spline segment for number of oocytes is connected 
with smoothed transitions (red line). The grey area represents the 95% CI. 
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Figure III: Spline Regression for the Danish and Dutch combined cohort. See footnote of 
figureI 
Figure II: Spline Regression for the Dutch cohort. See footnote of figure I
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Discussion
Our results indicate that a low oocyte yield in IVF treatment is not associated with 
an increased risk of having a trisomic pregnancy, irrespective of female age. Our 
results do not support the hypothesis that a lower number of follicles available after 
IVF with controlled ovarian stimulation is associated with higher aneuploidy rates.
The strengths of our study include its age-matched case-control design. Trisomy 
risk is strongly associated with maternal age. Our matched case-control design 
minimises residual age-related confounding. The statistical method we used is 
appropriate for clustered data and provided precise results, as shown by the narrow 
confidence intervals. 
The limitations of our current study are the lack of information on cycle number 
and on ovarian reserve test results. Moreover, we lacked information on the dose 
of gonadotropins used for controlled ovarian stimulation and on cycle cancellation 
policies. We have, however, no reason to assume that dosages differed between 
cases and controls. The data were matched by age, which is often used in clinical 
practice to determine a starting stimulation dose. Therefore it can be expected that 
within clusters the dosages of stimulation for cases and controls are correlated. For 
most women, smoking status and BMI were not available, so we could not adjust 
our analyses for these factors. Finally, this study did not include early pregnancy 
losses, in which non-viable trisomies occur more frequently. Therefore results of 
our study may be applicable to clinically confirmed pregnancies only.
This study analysed the limited pool hypothesis in a population of women who 
received controlled ovarian stimulation. Women with a low number of available 
antral follicles who achieve a spontaneous pregnancy may differ from women 
who conceived after controlled ovarian stimulation and IVF (Kline et al., 2011). In 
controlled ovarian stimulation treatment, less viable follicles and oocytes may be 
rescued preceding ovum pick up and selection of oocytes in the laboratory may 
further bypass natural selection that would have occurred in spontaneous ovulation 
followed by a conception. Thus, generalizability of our results to women who 
achieved spontaneous pregnancy may not be straightforward.
The Danish and Dutch combined cohort included patients who had IVF treatment 
between 1983 and 2011. Over these decades, techniques in oocyte collection did 
not change substantially (Kovacs, 1999; Wang and Sauer, 2006) and patients treated 
by newer techniques, such as cryopreservation or gamete donation, were not 
included in this study. Ovarian stimulation protocols, on the contrary, have changed 
over time, with a tendency to the use of lower dosages of stimulation (Macklon et 
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al., 2006). Therefore cases and controls were matched by year of treatment as well. 
Nevertheless, randomized control trials indicate little or no clinical benefits when 
higher dosage regimes are given to poor responders (Siristatidis and Hamilton, 2007) 
and differences in protocols have been shown to have no effect on aneuploidy rates 
(Gianaroli et al., 2010). In our analysis, we adjusted for the use of GnRH antagonists, 
which are known to decrease the average number of oocytes in IVF (Al-Inany et al., 
2011), but this did not change the risk of a trisomic pregnancy. 
Our overall current findings differ from our previously published results (Haadsma 
et al., 2010b). This may be due to differences in the methods and the characteristics 
of the two cohorts. The Dutch cohort previously published was analysed with 
multivariate conditional logistic regression and a higher risk of a trisomic pregnancy 
was observed in women who had less than 3 or 4 oocytes retrieved (OR 2.72, 95% 
CI 0.69-10.69 and OR 3.97, 95% CI 1.37-11.51 respectively). This was no longer 
observed in the current study when the Dutch data were analysed with GEE. 
This could indicate that our previous results had some sparse-data bias, i.e. an 
overestimation of results when small samples are analysed with conditional logistic 
regression (Greenland et al., 2000). The GEE analysis includes maximum likelihood 
to correct for bias (Greenland et al., 2000). 
The Dutch and Danish cohorts were comparable in the distribution of variables 
relevant for this analysis, including female age and the proportion of low oocyte 
yield. Overall, the characteristics of child-bearing women in the Netherlands and 
Denmark, such as fertility rates and age at first pregnancy, are comparable (Euro-
Peristat, 2013), and the overall prevalence of trisomies in both countries has 
remained stable over the study period (Loane et al., 2011). However, there are also 
differences between the two cohorts. Denmark has one of the highest rates for IVF 
treatment utility (Kupka et al., 2014; Ishihara et al., 2015), and therefore Danish 
women might have had a shorter duration of infertility at the start of IVF treatment 
(Pinborg et al., 2011). A longer duration of infertility might play a negative role in 
pregnancy rates after IVF treatment (Axmon and Hagmar, 2005).
Low oocyte yield after controlled ovarian stimulation in IVF is considered to reflect 
diminished ovarian reserve. However, there is no agreement in the literature on the 
definition of diminished ovarian reserve nor on which of its features are associated 
with poor outcomes (Cohen et al., 2015). Previous studies showed inconsistent 
results regarding the relation between various parameters reflecting diminished 
ovarian reserve (e.g. abnormal ovarian test results and previous ovarian surgery) and 
clinical outcomes (e.g. miscarriages and trisomic pregnancies) (van Montfrans et al., 
1999, 2002; Freeman et al., 2000; Kline et al., 2004, 2011; Grande et al., 2014). These 
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differences could be due to variation in definitions of low oocyte yield or diminished 
ovarian reserve used. Nevertheless, there is consensus on poor responders in IVF, 
as defined by the Bologna criteria (Ferraretti et al., 2011). Poor responders fulfilling 
these criteria are considered to have diminished ovarian reserve. The Bologna 
criteria define poor responders as women with two previous low oocyte yields 
(cycles cancelled or ≤ 3 oocytes) under optimum ovarian stimulation or women 
with at least 2 out of the 3 features: (i) maternal age ≥ 40 years, (ii) a previous low 
oocyte yield (cycles cancelled or ≤ 3 oocytes) and (iii) abnormal ovarian reserve test. 
These criteria better identify women with diminished ovarian reserve (Ferraretti 
and Gianaroli, 2014; Busnelli et al., 2015) compared to women with low oocyte 
yield in one IVF cycle only. 
Despite the large sample size of the Danish cohort and the Danish and Dutch 
combined cohort, the number of cases with low oocyte yield is still too small for 
final conclusions. Ideally, a prospective larger case-control study, focussing on 
poor responders as defined by the Bologna criteria, would determine whether this 
specific group is at an increased risk for trisomic pregnancies. However, collecting 
sufficient data for such a cohort of IVF-treated women will be a great challenge for 
an event as rare as trisomic pregnancy, especially if information on ovarian reserve 
tests for all patients with a low oocyte yield has to be included.
To conclude, our results are reassuring and indicate that low oocyte yield is not 
associated with an increased risk of a trisomic pregnancy. A small increase of risk 
may exist, but it would require a larger study to prove this.
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It is known that poor ovarian response (POR) after ovarian hyperstimulation in IVF 
treatment is associated with an increased risk of miscarriage. We hypothesized that 
repeated POR, as a marker of low oocyte quantity, is associated with miscarriage, 
while random POR in women with normal ovarian reserve is not. From a nationwide 
cohort of 8457 IVF-treated Dutch women, we selected 933 eligible women who 
had their first two IVF-cycles within one year and conceived after the second cycle. 
Women achieving an ongoing pregnancy (viable intra-uterine pregnancy ≥ 16 weeks) 
were compared to those experiencing a miscarriage (pregnancy loss between 4-16 
weeks). POR was defined as ≤ 3 oocytes at pick-up and normal ovarian response as ≥ 
4 oocytes. We analysed miscarriage risk in women with twice (4.6%), once (16.9%), 
and no (78.4%) POR. Women with twice POR more often experienced miscarriage 
(37.2%) compared to women with no POR (18.7%) (crude OR 2.57, 95%CI 1.35-4.91; 
adjusted for female age OR 2.21, 95%CI 1.14-4.28). Women with once POR did not 
have an increased risk of miscarriage (20.9%) compared to women with no POR, 
irrespective of whether POR occurred in the first or second IVF cycle.
Key words: miscarriage; poor ovarian response; IVF; Bologna criteria
Key message: Compared to women with no POR, women who had twice POR 
experienced miscarriage more often, whereas women with once POR did not. This 
finding supports the hypothesis that women with diminished ovarian reserve are at 
an increased risk of miscarriage, and women with a random POR are not.
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Nowadays overall miscarriage rates in IVF are comparable to rates observed in 
spontaneously conceived pregnancies (Tummers et al., 2003; McLernon et al., 
2016). However, some groups of IVF patients are at a higher risk of miscarriage. 
Sunkara and colleagues observed a 5-7% higher risk for women with a poor ovarian 
response (POR) during IVF treatment compared to women with normal response 
(Sunkara et al., 2014).
In most studies, POR is defined as ≤ 3 oocytes retrieved after ovarian hyperstimulation. 
POR may be the result of a diminished ovarian reserve (Ferraretti et al., 2011) or 
may occur as a random event in women with a normal reserve (Hendriks et al., 
2008). POR in the first IVF cycle does not imply POR in subsequent cycles. A second 
POR occurs in 36% of women after a first POR cycle (Klinkert et al., 2004) and cannot 
be prevented by changes in protocol or higher dosage of gonadotropins (Pandian 
et al., 2010).
According to the Bologna criteria, a poor responder has at least two of the following 
criteria: (a) age > 40 years, (b) previous POR or (c) abnormal ovarian reserve test 
results. In addition, two episodes of POR after hyperstimulation are sufficient 
to define a poor responder (Ferraretti et al., 2011). These poor responders are 
regarded to have a diminished ovarian reserve, i.e., low oocyte quantity. Women 
with low oocyte quantity have been hypothesized to have oocytes of low quality 
as well (Warburton, 1989; Kline et al., 2011), i.e., oocytes with DNA damage or 
chromosomal abnormalities (Holubcova et al., 2015; Marangos et al., 2015), which 
are strongly associated with early miscarriage (Voullaire et al., 2000; Wells and 
Delhanty, 2000; Jia et al., 2015). Thus, women with diminished ovarian reserve 
might be at an increased risk of miscarriage as compared to their peers with a 
normal ovarian reserve. Following this reasoning, we hypothesized that having a 
POR twice is associated with an increased risk of miscarriage while having a random 
POR is not.
In the present study, we have assessed whether women who had twice POR are at 
an increased risk of miscarriage compared to women who had once POR or no POR 
in their first two consecutive IVF cycles.
Material and methods
Women included in this study participated in the OMEGA-project, a cohort study with 
the primary objective to investigate the relation between ovarian hyperstimulation 
and risk of future hormone-related cancers. The OMEGA-project and the study
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Figure 1: Flow chart of women eligible for analysis.Footnote: The outcome of the first IVF 
cycle for the 933 eligible women was: 84% (780/933) of these women did not achieve a 
pregnancy, 8% (77/933) had a miscarriage and the remaining 8% had: no follicle aspiration 
(56/933) , immature delivery (6/933), live birth (2/933) or unknown outcome (12/933).
Pregnant after  
second IVF cycle 
n = 1065 
Ongoing pregnancies (>16 weeks) n=817 
Miscarriages (≤ 16 weeks)  n=209 
Total pregnancies n= 1026 
Second IVF cycle  
within one year after the first  
n = 5472 
Excluded if pregnancy is 
ectopic n = 36 or         
terminated n = 3 
Excluded if ovarian response 
of one or both IVF-cycles  
unknown n = 57 or                     
clomiphene use n = 36 
Selected: 
Ongoing pregnancies n = 747  
Miscarriages n = 186 
Total Pregnancies N=933 
First IVF-cycle 
n = 8457 
Excluded if no second cycle 
within one year            
  n=2985 
Excluded if not pregnant after 




population have been described in detail previously (de Boer et al., 2003). Briefly, 
the cohort included infertile women who visited one of the 12 Dutch IVF-clinics 
between January 1, 1983 and January 1, 1995. In the OMEGA-project, information 
about lifestyle and reproduction were obtained via questionnaires. Additional 
information regarding causes of infertility, cancelled cycles and outcome of 
treatment were retrieved from medical files by trained research assistants after 
written permission from patients was given. All institutional ethics committees of 
the participating clinics and the Surveillance Committee of the Netherlands Cancer 
Registry approved the study procedure. Exclusion criteria were lack of information 
on IVF cycles or ovarian response, oocyte or embryo-donation, gamete or zygote 
intrafallopian transfer and intracytoplasmic sperm injection, leaving 8457 women 
with first IVF cycles (Lintsen et al., 2005). Women eligible for the present study 
had their first and second IVF cycle within one year, with the outcome after 
the second cycle being either an ongoing pregnancy or a miscarriage. Women 
with clomiphene use for hyperstimulation, induced abortion or an extra uterine 
pregnancy were excluded. Finally, women who had ovulated before ovum pick-up 
or had complications during oocyte retrieval according to the medical records were 
excluded since this may have reduced the total number of oocytes retrieved. In the 
first cycle, cancellation due to expected ovarian hyperstimulation syndrome or POR 
were classified as normal response or POR respectively, to avoid selection bias. We 
have published a previous analysis on data from the OMEGA-project regarding the 
risk of miscarriage in women with POR in their first cycle (Haadsma et al., 2010a). 
The present study investigated women who had POR in their first and second IVF 
cycle, and therefore it comprises a different dataset within the OMEGA-project 
database.
Ovarian response was defined as normal when ≥ 4 oocytes were retrieved and defined 
as POR when ≤ 3 oocytes were retrieved. Miscarriage was defined as spontaneous 
loss of an intrauterine pregnancy between 4 and 16 weeks gestation. Karyotyping 
of miscarriage tissue was not performed. A viable intrauterine pregnancy of at least 
16 weeks was defined as an ongoing pregnancy. Female age was defined as age at 
the start of the first IVF cycle. Pregnancy outcomes of the second IVF cycle were 
compared between women with an ongoing pregnancy and women experiencing a 
miscarriage. Women were divided into three response categories: twice POR (POR 
in the first and second cycle), once (POR in the first or second cycle) and no POR (no 
POR, neither in the first or second cycle). 
We performed logistic regression analysis to calculate the odds ratios (ORs) for 
miscarriage. Potential confounders, including female age, cause and duration of 
infertility, previous miscarriage, dosage of gonadotropin, body mass index and 
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smoking characteristics were evaluated using Chi-squared, Student’s T, Mann-
Whitney U and Kruskal-Wallis tests. The ORs were adjusted for factors associated 
with both outcome (ongoing pregnancy or miscarriage) and response categories 
(twice, once or no POR). Interaction between risk of miscarriage and other potential 
risk factors was assessed using product terms. Stratified analyses were performed 
in subgroups of women ≤ 35 years and > 35 years to assess potential residual 
confounding by age. Sensitivity analysis excluding women who had a history of ≥ 
2 miscarriages was performed to exclude possible interference from women with 
repeated pregnancy losses due to other aetiologies. A p-value less than 0.05 was 
considered significant. Analyses were performed using IBM SPSS Statistics software 
version 20.
Results
Figure I shows the selection process for eligible patients. There were 8457 women 
undergoing their first IVF-cycle, of whom 5472 had their second cycle within one 
year, resulting in 1065 pregnancies. After exclusions (see figure I), there were 933 
women eligible for analysis; 747 women had an ongoing pregnancy and 186 had a 
miscarriage. 
Table I shows patient characteristics according to pregnancy outcome groups. 
Patient characteristics were similar for women with ongoing pregnancies and 
women experiencing miscarriage, except for age, duration of infertility, and response 
categories. There was a statistically significant increasing risk of miscarriage in 
women with no, once and twice POR (miscarriage rates 18.7%, 20.9% and 37.2% 
respectively; p = 0.01). 
Table II shows patient characteristics according to POR categories. Twice POR 
occurred in 4.6% (43/933) of women, once POR in 17.0% (158/933) and no POR in 
78.4% (732/933). After having POR in their first IVF cycle, 33% of women (43/129) 
had POR in the second cycle. Women with twice POR were older than women with 
once and no POR (35.3, 33.5 and 32.3 years, respectively). The average dosage 
of gonadotropin received in the first cycle was comparable in all three response 
categories. Women with POR in the first cycle received, on average, a higher dosage 
of gonadotropin in the second cycle. In the second cycle, the average dosage of 
gonadotropin given to women with once and twice POR was not statistically 
different (p = 0.52), but both were significantly higher than the average dosage 
of gonadotropin given to women with no POR (p < 0.01). Age was the only factor 
associated with both outcome (ongoing pregnancy or miscarriage) and response 
categories (twice, once or no POR). 
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Table I: Characteristics of women with an ongoing pregnancy or miscarriages after their 
second IVF cycle.
Footnote: values are mean ± standard deviation (range in parentheses) or counts (percentages 
in parentheses). P-value for the differences between women with ongoing pregnancies and 
miscarriage. BMI, body mass index (kg/m2), HMG, human menopausal gonadotropin, FSH, 
follicle-stimulating hormone, POR, poor ovarian response. 
avalue for the difference between groups, bStudent’s T- test, cMann-Whitney U test, dχ2 test, e 
Total dosage in international units
 Number of
pregnancies
total   
N= 933 
Ongoing pregnancy 
 n = 747 
Miscarriage 
 n = 186 
 pa
Age, years 933 32.4 ±3.7 (21.0-42.8 ) 33.3 ± 4.4 (23.1-43.1) 0.01b
BMI 894 22.2 ± 3.3 (14.5-43.6) 22.4 ±3.4 (16.4-37.6) 0.85c




Tubal factor 340 273/684 (39.9%) 67/167 (40.1%) 
Male factor 239 188/684 (27.5%) 51/167 (30.5%) 
Unexplained 208 172/684 (25.1%) 36/167 (21.6%)
Other 64 51/684 (7.5%) 13/167 (7.8%) 
Duration of 
infertility, yrs
800 5.2 ±2.9 (0.1-20.2) 5.9 ±3.3 (0.8-18.3) 0.01c
Previous 
miscarriage




933 85 (11.4%) 18 (9.7%) 0.51d
Total dosage of hyperstimulation 1st cyclee





Total dosage of hyperstimulation 2nd cyclee






Twice POR 43 27/747 (3.6%) 16/186 (8.6%)
Once POR 158 125/747 (16.7%) 33/186 (17.7%)

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Adding the other characteristics to the model did not change the odds ratio 
materially. There was no interaction between response categories and female 
age, dosage of gonadotropin, body mass index, miscarriage prior to the first IVF 
treatment, and smoking. For the women with once POR, miscarriage rates were 
comparable between women experiencing POR in their first or in their second IVF 
cycle (20.2% (24/119) and 23.1% (9/39) respectively; p = 0.70).
Table III shows the distribution of ongoing pregnancies and miscarriages, and the 
risk of miscarriage according to the response categories. No POR was the reference 
category. Women who had twice POR more often experienced miscarriage compared 
to women who had no POR (crude OR 2.57, 95%CI 1.35-4.91). When adjusted for 
female age, twice POR was still associated with a higher risk of miscarriage compared 
to no POR (adjusted OR 2.21, 95%CI 1.14-4.28). Women with once POR did not have 
an increased miscarriage risk compared to women with no POR (crude OR 1.15, 
95%CI 0.75-1.76, age-adjusted OR 1.08, 95%CI 0.70-1.66).
Women who had a miscarriage prior to IVF treatment had an increased risk of a 
miscarriage during IVF treatment, although not statistically significant (OR 1.49 
95%CI 0.92-2.43). Out of the 933 women included, 49 (5.3%) experienced ≥ 2 
miscarriages, including miscarriages reported prior to IVF-treatment and occurring 
during the first two cycles. Of the women with ≥ 2 miscarriages, 8.2% (4/49) had 
twice POR, 24.5% (12/49) had once POR and 67.3% (33/49) did not have POR. 
Analyses were repeated excluding the 49 women with a history of ≥ 2 miscarriages: 
women with twice POR still had a higher risk of miscarriage (adjusted for age, OR 
2.11 95%CI 1.03-4.35) compared to women with no POR, while women with once 
POR still had no increased risk of miscarriage (adjusted for age, OR 0.90 95%CI 0.54-
1.48).
Figure II shows percentages of miscarriage depending on response categories 
stratified for groups of women ≤ 35 years and >35 years. For both age groups, 
women with twice POR had a higher risk of miscarriage compared to women with 
no POR, but this was only statistically significant for the women ≤ 35 years (OR 3.86, 













































Our results show that women with twice POR in their first two consecutive IVF 
cycles more often experienced miscarriage compared to women with no POR, also 
after adjustment for female age. Women with once POR did not have an increased 
miscarriage risk compared to women with no POR, irrespective of whether the 
POR occurred in the first or second IVF cycle. These results support the hypothesis 
that women with diminished ovarian reserve , reflected by twice POR, are at an 
increased risk of miscarriage and women with a random POR are not.
Strengths of this study are the analysis of two consecutive hyperstimulation cycles 
within one year, and assessment of possible confounders such as female age, 
smoking, BMI, miscarriage prior to IVF treatment and dosage of gonadotropins. 
The average gonadotropin dosage was increased in the second cycle in case POR 
was experienced in the first cycle; the possibility of underdosage as the cause of 
repeated POR is thus unlikely. For this study we selected women who underwent 
their first two IVF cycles within one year. We (arbitrarily) chose this cut-off to ensure 
that the ovarian reserve status of the woman during the first and second cycle would 
be more or less comparable. However, using this cut-off also precludes selection of 
women with an ongoing pregnancy after their first IVF cycle.
Limitations of this study include the fact that no ovarian reserve tests were 
performed. Poor responders in our study were identified solely by the criterion 
of experiencing POR twice, which is only one of the criteria for the definition of 
poor responders (Ferraretti et al., 2011). More poor responders would have been 
identified if ovarian reserve test results would have been available. Furthermore, 
we used an early dataset (1983-1995) in a period in which stimulation protocols 
used agonists and were usually “short flare up” and “downregulation” protocols. 
However, there is no evidence of a specific hyperstimulation protocol being more 
beneficial than others for POR patients (Pandian et al., 2010; Bosdou et al., 2016) 
and no differences have been shown in miscarriage rates between agonist and 
antagonist protocols (Al-Inany et al., 2016). 
This study was not designed to investigate specific causes for repeated pregnancy 
loss, such as anti-phospholipid antibodies, chromosomal translocation in the couple 
and acquired or congenital uterine abnormalities. However, excluding women 
with a history of ≥ 2 miscarriages from the analyses still showed a higher risk of 
miscarriage for women with twice POR.
Our study contributes to the literature since it specifically describes a poor 
71
4
responder population based on the Bologna criteria and the risk of miscarriage. 
Heterogeneity in the definition of POR used in the literature has led to different risks 
of miscarriage between studies. No association with miscarriage was found when a 
higher threshold for the number of oocytes was used to define poor response. This 
may well be due to the inclusion of more women with a random POR (Sutter and 
Dhont, 2003; Kumbak et al., 2009; Setti et al., 2011). Our findings are in accordance 
with studies in which POR is defined as ≤ 3 oocytes (Haadsma et al., 2010, Sunkara 
et al., 2014). Our results support the hypothesis that this observed increased risk 
of miscarriage after POR is explained by women with a diminished ovarian reserve 
and hence an allegedly lower oocyte quality, and is absent in women with normal 
ovarian reserve experiencing a random POR.
In line with this is the finding that women with normal ovarian reserve test results 
experiencing a random POR in their first cycle and normal ovarian reserve test 
results have comparable blastocyst quality (Arce et al., 2014) and live birth rates 
(Moolenaar et al., 2013) as women without POR. 
The Bologna criteria define poor responders, but it has been argued that the 
different categories within the Bologna criteria (Marca et al., 2015) represent 
different subgroups (Alviggi et al., 2016). There is growing evidence that the 
different subgroups of patients fulfilling the Bologna criteria are homogeneous for 
poor prognosis (Busnelli et al., 2015; Bozdag et al., 2017). However, specifically 
young women fulfilling the Bologna criteria for POR are suggested to have more 
favourable outcomes than women of advanced age. In our stratified analysis of the 
data only for women ≤ 35 years or > 35, the younger women with twice POR still 
had a higher risk of miscarriage when compared to no POR, showing that younger 
age does not protect for the effect of twice POR on risk of miscarriage.
For clinical practice, our results imply that women with POR in IVF achieving a 
pregnancy should not invariably be warned for a higher risk of miscarriage, but 
be counselled based on the criteria for poor responders including their previous 
oocyte yield.
To ensure generalizability of our results we suggest replication of our study in a 
different cohort, preferably including the results of ovarian reserve tests and 
different stimulation protocols using antagonist regimes.
In conclusion, our study shows that women with twice POR have an increased 
miscarriage risk compared to women without POR, also after adjustment for female 
age, whereas women with once POR and once a normal ovarian response do not. 
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This finding suggests that the increased risk of miscarriage observed after POR is 
applicable to women with POR resulting from diminished ovarian reserve and not 
to women with random POR. Our results support the hypothesis that low oocyte 
quantity, as reflected by repeated poor response, is associated with low oocyte 
quality, as reflected by miscarriage.
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Background: Miscarriage is the most common adverse outcome in pregnancy and 
maternal smoking increases this risk. It is unclear whether miscarriage risk is also 
increased in women who were exposed to cigarette smoke in-utero due to smoking 
of their mother. 
Objective: This study investigates whether women exposed to cigarette smoke in-
utero have a higher risk of having a miscarriage later in life. 
Methods: This is a study within the Avon Longitudinal Study of Parents and Children 
(ALSPAC) cohort (n=15445). Participants were pregnant women residing in the Avon 
County, UK. We used obstetric history data regarding pregnancies occurring before 
1992 that were obtained from medical records and questionnaires from participants 
(n=7160, after exclusions).
Results: Participants who were exposed to cigarette smoke in-utero (n= 2049/7160, 
28.6%) had a higher risk of ever having a miscarriage (33.7% versus 30.9%; adjusted 
OR 1.12, 95%CI: 1.00, 1.27) compared with participants who were not exposed. 
The risk of one previous miscarriage was not influenced by being in-utero exposed 
(OR 1.08, 95%CI: 0.95, 1.23). However, the risk of having two (OR 1.30, 95%CI: 
1.02, 1.67) or three or more (OR 1.17, 95%CI: 0.80, 1.69) previous miscarriages 
was higher for participants exposed in-utero. There was an interaction between 
in-utero exposure and three factors: packyears of the participants, passive smoke 
exposure from other household members, and age at first and last pregnancy of the 
participants. Participants exposed in-utero who were ever smokers had an increased 
risk of miscarriage (OR 1.26, 95% CI: 1.11, 1.52) while participants exposed in-utero 
who were never smokers did not (OR 0.93, 95% CI: 0.78, 1.12). 
Conclusion: There was a small but statistically significant increased risk of miscarriage 
following in-utero exposure to cigarette smoke, which was higher for ever smokers 
but not observed for never smokers. 




Miscarriage is the most common adverse outcome in pregnancy (Regan and Rai, 
2000) and maternal smoking is a well-known avoidable risk factor for miscarriage 
(Shiverick and Salafia, 1999). In 2014, in the UK, 17% of the adult women were 
smokers, of which 11% were pregnant and smoking women (Office for National 
Statistics, 2016). 
It is hypothesized that in-utero smoke exposure can compromise the reproductive 
health of the unborn child in the long-term. In females, reproductive programming 
is mainly established during the embryonic and foetal period (Grive and Freiman, 
2015; Kermack et al., 2015). During this period the reproductive programming is 
especially susceptible to harmful agents such as cigarette smoking (Dechanet et 
al., 2011; Fowler et al., 2014; Camlin et al., 2016) and cigarette smoking can have 
long lasting effects later in life (Yasui et al., 2012). Previous studies suggest that in-
utero smoke exposure is associated with reduced fecundability (Jensen et al., 1998, 
2006), altered hormone levels around puberty, earlier age at menarche (Ernst et 
al., 2012; Gollenberg et al., 2015) and may possibly even affect age at menopause 
(Strohsnitter et al., 2008). 
The suggested pathophysiological mechanisms involve reduction in the number 
of female germ cells, as shown in mice exposed in-utero and human foetal 
ovaries (Lutterodt et al., 2009; Camlin et al., 2016) and reduction of the quality 
of the remaining germ cells. Meiotic errors due to alterations in spindle formation 
were observed in mice exposed in-utero (Camlin et al., 2017). These alterations 
are associated with aneuploidies in the oocytes (Eichenlaub-Ritter, 2012), which 
are a major cause of miscarriage. There is one previous study showing a slightly 
higher but non-significant association between in-utero smoke exposure and late 
miscarriage between 17-20 weeks of gestation (HR 1.23, 95%CI: 0.72, 2.12) (Cupul-
Uicab et al., 2011). Therefore, we further explored the hypothesis that smoking 
during the foetal period has a long lasting adverse effect on the reproductive health 
of the unborn daughter. The aim of our study was to answer the question whether 
in-utero exposure to cigarette smoke is associated with a higher risk of miscarriage 
later in life.
Materials and Methods
The present study is based on data of women recruited to participate in the 
Avon Longitudinal Study of Parents and Children (ALSPAC). The ALSPAC study was 
established to investigate environmental and genetic factors that could potentially 
influence the health of parents and children (Golding, 1990; Boyd et al., 2013). The 
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full description of the ALSPAC cohort has been previously reported (Fraser et al., 
2013). Briefly, all pregnant women (the participants, subject of this study) residing 
in the Avon County, with expected date of delivery for the index child between 
1st April 1991 and 31st December 1992 were invited to enrol in the study. Initially, 
15445 women (i.e. approximately 90% of all pregnancies in the study area for the 
enrolment period) were enrolled in the study. Participants were recruited by local 
press (radio, television, posters), local community midwives and during routine 
ultrasound examinations. Questionnaires were pilot tested and validity of the 
questionnaires was assessed by comparing answers regarding the participants’ 
obstetric history, prescribed medication and morbidity with their medical records. 
The agreement was found to be 95% (Golding et al., 2001). 
Characteristics and obstetric history of the participants were obtained from medical 
records and questionnaires answered during the gestational period of the index 
child. The medical records described all miscarriages of 20 weeks or less. When 
pregnant of the index child, participants were asked “were you pregnant before?; 
if yes, how many times? ”and “did you ever have a miscarriage?; if yes how many 
times?”. The ALSPAC study aimed to follow parents and the children resulting from 
the index pregnancy. As a result, the majority of the participants whose index 
pregnancy resulted in a miscarriage were excluded from further assessments. 
Therefore, the current study did not analyse the outcome of the index pregnancy, 
but assessed the preceding pregnancies only, to avoid selection bias. The obstetric 
history of the women analysed for this study comprises the period between the first 
and last pregnancy preceding the index pregnancy.
The obstetric history included self-reported information regarding previous 
miscarriages, abortions or terminations, stillborn babies/stillbirth, babies born alive 
who died later, and birth weight and term of delivery.
 Questions regarding the exposure of interest, i.e., in-utero cigarette smoke 
exposure of the participants, were answered by the participants at two different 
time points: when participants were pregnant of the index child and eight years 
later. Participants were asked : “did your mother smoke when pregnant of you” 
and participants could answer: “yes”, “no” or “don’t know”. Answers from both 
time points were compared and inconsistent answers ( changes from “yes” to “no” 
or vice-versa) were excluded. Participants who answered “don’t know” in both 
time points were excluded as well. Women who at first answered “don’t know” 
but gave a positive or negative answer eight years later were reclassified based on 
the assumption that they retrieved the information, e.g. from their mothers after 
having been asked for the first time. The consistency between responses from two 
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time points was assessed by calculating Cohen’s Kappa. Please note that the study 
website contains details of all the data that is available through a fully searchable 
data dictionary available at http://www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary. Ethical approval for the study was obtained from the ALSPAC Ethics 
and Law Committee and the Local Research Ethics Committees available at http://
www.bristol.ac.uk/alspac/researchers/research-ethics
Statistical Analysis
The risk of having a miscarriage was analysed in two different ways. First as a binary 
outcome (ever had a miscarriage yes or no) using logistic regression analysis, to test 
the hypothesis whether in-utero smoke exposure is associated with a higher risk of 
ever having a miscarriage. In a second analysis, the number of previous miscarriages 
was analysed using multinomial regression analysis, to test the hypothesis whether 
in-utero smoke exposure had an effect on the occurrence of one, two or three or 
more miscarriages. Differences between participants who were in-utero exposed or 
not exposed were assessed via independent sample Students T-test, Mann-Whitney 
U test or Chi-Square test when appropriate. Potential confounders were factors 
identified in the data to be a predictor of miscarriage (i.e. statistically significantly 
associated with miscarriage in the univariate analysis) and associated with in-utero 
exposure. Interaction between in-utero exposure and other factors was explored by 
adding interaction terms to the regression analysis.
There were three levels of smoke exposure: in-utero ( mother of the participants 
smoking when pregnant of the participant), active smoking (smoking of the 
participants themselves; ever smokers (current or previous) or never smokers) and 
passive smoking ( exposure of the participants due to smoking of father, partner or 
other household members).
Packyears were calculated for the participants who were ever smokers. The 
maximum number of cigarettes smoked per day, as reported by the participants was 
divided by 20 and multiplied by the duration of exposure ( age of the participant at 
index pregnancy minus age when the participant started smoking minus years since 
they stopped smoking for previous smokers). The packyears were categorized into: 
light smoker (0-9.9 packyears), moderate smoker (10-19.9 packyears) and heavy 
smoker (20 or more packyears).
Sensitivity analysis without reclassification of in-utero exposure of the participants 
and with participants who were excluded from the analyses were performed to 
evaluate any differences in results due to reclassification or exclusions.
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Figure I: Flow chart of eligible participants. Footnote: a. Participants with incompatible 
number of miscarriages per number of pregnancies b. Participants who answered ‘Don’t 
know’ to the question about in-utero exposure in the first questionnaire, but indicated they 
were exposed (n=87) or not exposed (n=137) in a later questionnaire were reclassified and 
included in the study.




Not exposed in-utero 
n=5111 
In-utero exposure: 
“Did your mother smoke when pregnant of you?” 
n=7160 
Response  












No information if 
previously pregnant 
n=2057 
Inconsistenciesa n=117 Question about in-utero exposure 
“Did your mother smoke when pregnant of you?” 
n=8702 




The initial cohort included 15243 unique participants. After exclusions (n=8013, 
see figure I), 7160 participants were included in the analyses, of which 28.6% 
(2049/7160) were exposed to cigarette smoke in-utero. 
Table I shows characteristics of the participants. Compared to participants who were 
not in-utero exposed, participants who were in-utero exposed were, on average, 
younger at first (22.1 years of age versus 23.9) and at last pregnancy (27.2 years 
of age versus 28.6), were more often underweight (13.7% versus 10.9%) or obese 
(6.6% versus 4.8%), had a lower educational level (CSE level 25.4% versus 12.6%) 
and more often had diabetes (1.8% versus 0.9%). Overall, the proportion of ever 
smokers (current or previous smokers) was high for both groups (60.2% and 47.7%) 
but the in-utero exposed participants started smoking earlier (15.8 years of age 
versus 16.6), were more often current smokers (47.1% versus 29.0%), had higher 
levels of packyears (7.8 packyears versus 6.9) and more often had fathers (89.4% 
versus 70.3%), partners (47.1% versus 35.3%) and other household members who 
were smokers (6.7 % versus 3.6%) . 
Table II shows crude OR of potential determinants of miscarriage. These factors 
were: the interval between first and last pregnancies (OR 1.03 95%CI: 1.02, 1.05) 
and age at first (OR 1.00, 95% CI: 0.99, 1.01- see also categories in table II) and last 
pregnancy (OR 1.03, 95%CI: 1.01, 1.04), smoking of participants (ever smokers (OR 
1.11, 95%CI: 1.00, 1.22), current smoker (OR 1.13, 95%CI: 1.01, 1.27) and packyears 
(OR 1.02, 95%CI: 1.02, 1.02)), passive smoking due to exposure to smoking by father 
(OR 1.16, 95%CI: 1.03, 1.31) and other household members (OR 1.40, 95%CI: 1.11, 
1.77).
Adjusted analyses were therefore corrected for: interval between and age at first 
and last pregnancy, packyears, passive exposure by father and other household 
smokers. Current smokers and years stopped smoking were also associated with 
miscarriage, but we decided to correct for one smoking variable to avoid inclusion 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table III shows OR of ever having a miscarriage associated with in-utero exposure. 
Participants who were in-utero exposed had a higher risk of ever having a 
miscarriage (crude OR 1.14, 95%CI: 1.02, 1.27 and adjusted OR 1.12, 95%CI: 1.00, 
1.27) compared with participants who were not in-utero exposed. When excluding 
ever smokers from the analysis, participants who were in-utero exposed and were 
never smokers did not have a higher risk of ever having a miscarriage (crude OR 
0.93, 95%CI: 0.78, 1.11 and adjusted OR 0.93, 95%CI: 0.78, 1.12). On the other 
hand, participants who were ever smokers and were in-utero exposed had a higher 
risk of miscarriage (crude OR 1.29, 95%CI: 1.11, 1.49 and adjusted OR 1.26, 95%CI: 
1.11, 1.56) compared to ever smokers who were not exposed in-utero and this risk 
was higher for moderate smokers (crude OR 1.39, 95%CI: 1.03, 1.89 and adjusted 
OR 1.47, 95%CI: 1.06, 2.03) than for light smokers (crude OR 1.28 95%CI: 1.08, 1.53 
and adjusted OR 1.29, 95%CI: 1.06, 1.56). However, although participants who 
were heavy smokers had a higher risk of miscarriage compared to moderate or light 
smokers (table II), heavy smokers who were also exposed in-utero did not have 
higher risk than heavy smokers who were not exposed in-utero (crude OR 0.84, 
95%CI: 0.42, 1.70 and adjusted OR 0.78, 95%CI: 0.37, 1.61). Participants who were 
ever smokers and had maximum exposure ( in-utero and passive smoking: father, 
partner and other household smokers had the highest risk for miscarriage (crude 
OR 2.58, 95%CI: 1.46, 4.56 and adjusted OR 2.71, 95%CI: 1.44, 5.11) compared to 
participants who had no in-utero exposure, were never smokers and had no passive 
smoke exposure. 
Table IV shows OR for categories of one, two, three or more miscarriages associated 
with in-utero exposure. The risk of one previous miscarriage was not influenced by 
being in-utero exposed (crude OR 1.07, 95%CI: 0.95, 1.21 and adjusted OR 1.08, 
95%CI: 0.95, 1.23). However, the risk of having two (crude OR 1.32, 95%CI: 1.06, 
1.65 and adjusted OR 1.30, 95%CI: 1.02, 1.67) or three or more (crude OR 1.36, 
95%CI: 0.97, 1.91 and adjusted OR 1.17, 95%CI: 0.80, 1.69) previous miscarriages 
was higher for participants exposed in-utero. 
In the logistic regression there was a statistically significant interaction between 
being exposed in-utero and ever (current or previous) being a smoker (p=0.01) and 
packyears (p=0.02), being exposed to other household smokers (p=0.02) and age at 















































































































































































































































































































































































































































































































































































































































































































































































































































































































Among participants who were excluded from analysis (n=8083, see figure I), 
there were 4307 participants with unknown in-utero exposure status. Among the 
remaining participants, 25.7% (971/3776) were exposed in-utero. This is a 2.9% 
difference ( Pearson Chi-Square test p-value= 0.001) with participants included in 
the analysis. We have repeated the analysis for the association between the risk of 
ever having a miscarriage and in-utero exposure, including this group which was 
previously excluded and found only slightly different results (crude OR 1.20, 95% CI: 
1.08, 1.32; adjusted OR 1.13, 95% CI: 1.00, 1.27).
The Kappa value for the agreement between “yes” and “no” answers at the index 
pregnancy time point and 8 years later was 0.88 (n=2550, p=0.01). To evaluate the 
impact of reclassification of in-utero smoke exposure after the second time point 
we have repeated the analysis for the association between risk of ever having a 
miscarriage and in-utero exposure without the reclassified participants and we 
found similar results (crude OR 1.13, 95% CI: 1.01, 1.26; adjusted OR 1.12, 95% CI: 
0.99, 1.27).
Discussion
In our study, there was a small but statistically significantly increased risk of having 
a miscarriage for participants who were exposed to cigarette smoke in-utero. 
There was an interaction between in-utero smoke exposure and participants age 
at first and last pregnancy, smoking of participants themselves, and exposure to 
other smoking household members, leading to an additional increment in the 
risk for miscarriage. However, the same was not observed for never smokers who 
were exposed in-utero. This indicates that in-utero smoke exposure may not be an 
independent risk factor for miscarriage, but rather an modifier of the effect of being 
an active or passive smoker on the risk of miscarriage. 
Moreover, for participants who had two or more miscarriages, being in-utero 
exposed increased the risk, whereas for participants with one miscarriage, there 
was no effect of previous in-utero smoke exposure. This could indicate that in-utero 
exposure plays a more relevant role in the occurrence of repeated miscarriages 
than in the occurrence of an occasional isolated miscarriage. 
Participants who were heavy smokers had a higher risk of miscarriage compared 
to moderate or light smokers. However, heavy smokers who were also exposed in-
utero did not have higher risk than heavy smokers who were not exposed in-utero. 
This could indicated that heavy smoking determines the miscarriage risk first and 
foremost.
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The literature regarding in-utero smoke exposure and risk of miscarriage is scarce. 
One previous study on adverse pregnancy outcome included 76357 pregnancies 
from 1999 to 2008 from the Norwegian Medical Birth Registry, reporting 59 late 
miscarriages (between 17-20 weeks gestational age) (Cupul-Uicab et al., 2011). The 
rate of in-utero cigarette smoke exposure was 28%, which is comparable to 28.6% 
in-utero exposure in our cohort. Although the analyses of the Norwegian data 
were based on time to miscarriage, the hazard ratio for late miscarriage in women 
exposed to cigarette smoke in-utero (HR 1.23, 95%CI: 0.72, 2.12) was similar to our 
results, in the UK ALSPAC cohort (Cupul-Uicab et al., 2011).The Norwegian authors 
concluded that there was a slightly increased risk of miscarriage for women exposed 
to cigarette smoke in-utero, although they had limited statistical power, since 
they included only late miscarriages. Our study included all miscarriages up to 20 
weeks gestation, therefore our findings are not specific for late miscarriages. In our 
analyses, we had enough statistical power to find a small effect and we therefore 
agree with the conclusion of the study by Cupul-Uicab and colleagues. Additionally, 
we were able to analyse the number of miscarriages and show an increased risk for 
recurrent miscarriages. 
How in-utero smoke exposure can jeopardize the reproductive capacity of the 
exposed daughters later in life is not univocally clarified. Smoking is known to have an 
effect on all stages of reproductive functions , i.e., folliculogenesis, steroidogenesis 
(impairment of oestrogen synthesis), tubal function, embryo transport through 
fallopian tube, later implantation and myometrial activity (Dechanet et al., 2011; 
Richardson et al., 2014). Similar effects are observed in animal model studies on 
the effect of in-utero exposure. The follicles and oocytes of female mice offspring 
who were in-utero exposed via mainstream nasal cigarette smoke of their pregnant 
mothers displayed ovaries with abnormal somatic cell proliferation, increased 
apoptosis and consequently a reduction in follicle numbers (Camlin et al., 2016). 
Furthermore, an increased time to conception has been shown for in-utero exposed 
mice, although no changes in ovarian development or preimplantation embryo 
development were found (Camlin et al., 2017). This suggests that alterations 
associated with in-utero exposure might occur at the follicular level. The reduction 
in somatic cells observed in animal studies is consistent with the sole study with 
human data. Human foetal ovaries obtained from 29 legal abortions (38 to 64 days 
post conception) had a reduced number of somatic cells of the ovaries after in-
utero cigarette smoke exposure (Lutterodt et al., 2009). Although there was a non-
significant reduction in the number of the oogonias as well, the reduction in somatic 
cells may be crucial since oocytes are enclosed in follicles (which contain somatic 
cells) to survive. The cellular mechanism involving the reduction in cell numbers 
might include aryl hydrocarbon receptors and disruption of oestrogen signalling 
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(Fowler et al., 2014) leading to reduction of foetal ovarian germ cell proliferation. 
Another suggested mechanism was alterations in DNA methylation, which has been 
found in cord blood cells of exposed babies of the index pregnancy of the ALSPAC 
participants (Richmond et al., 2015), in a Norwegian cohort (Joubert et al., 2012), 
and in peripheral blood cells of adolescents (Lee et al., 2015), demonstrating how 
alterations in DNA methylation are maintained postnatally. 
In-utero cigarette smoke exposure is associated with higher risk of nicotine 
dependence for the exposed foetuses later in life (Oncken et al., 2004) leading to 
an increased risk of an earlier start and persistency of smoking behaviour later in 
life (Cornelius et al., 2000). Indeed, we observed in our data that in-utero exposed 
participants showed increased odds of smoking behaviour. Therefore, women 
who were exposed in-utero presumably have a higher risk of having a miscarriage 
because they are more likely to be a smoker themselves and to separate these 
effects, we analysed never smokers, ever smokers and level of smoking separately 
and found different results depending on smoke habits of the participants. 
This study contributes to the scarce literature regarding in-utero cigarette smoke 
exposure and miscarriage risk. Strengths of this study includes the large sample size, 
assessment of various important potential confounders, low chance of selection 
bias due to small difference of in-utero smoke exposure between participants 
included and excluded in the analyses. The questionnaires were internally validated 
with pilot testing to guarantee clear questions and to avoid confusion in responses, 
and later compared with medical records, showing a 95% agreement rate. To avoid 
misclassification and reduce recall bias for in-utero exposure, agreement between 
questionnaires from different time points was assessed and it showed high kappa 
level of agreement, meaning that the majority of the participants were consistent in 
their answers in questionnaires administered at enrolment period and eight years 
later. Indirect evidence for in-utero smoke exposure was found in the comparison 
between birth weights of exposed and not-exposed participants, showing lower 
average birth weight in exposed participants. 
Limitations of this study include unknown gestational age and lifestyle characteristics 
at time of the miscarriages, and the level of in-utero exposure ( number of cigarettes 
smoked per day by the mother of the participants). 
Firstly, the lack of gestational age at miscarriage resulted in the impossibility of this 
study to answer the question at which gestational age the highest proportion of 
miscarriages might have occurred due to previous in-utero smoke exposure. 
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Secondly, because the level of in-utero exposure was unknown, our results could 
be underestimating higher exposure levels if the effect of in-utero exposure has 
a similar dose-dependent effect on miscarriage as cigarette smoking in adulthood 
(Pineles et al., 2014). Childhood cigarette smoke exposure was not asked in the 
questionnaires directly, but data on paternal smoking habits were available and 
might have contributed to passive smoke exposure of the participants during 
childhood. 
Finally, due to the retrospective study design, the lifestyle characteristics of 
participants collected during the pregnancy of the index child were taken to 
adjust estimates for miscarriages occurring prior to the index pregnancy. Our main 
concerns regarded age of the participants and smoking status. The risk of miscarriage 
increases with advancing age, therefore we stratified our analyses for age groups, 
calculated an interval between first and last pregnancy and adjusted the analyses 
for these factors. The adjusted results continued to be significant and similar to the 
crude analysis. We took smoking status of participants at time enrolment period 
as a proxy of smoking status when miscarriages occurred because these data were 
not available for previous pregnancies. Additionally, packyears were calculated with 
the maximum number of cigarettes smoked to estimate the level of active cigarette 
smoking for the participants. A national survey about smoking habits in Great Britain 
from 1974 to 2014 shows a decrease in the percentage of smokers from 46% to 20% 
over the decades, meaning a reduction of 0.65 % per year, and also a linear fall, year 
by year, in the number of cigarettes consumed daily (Office for National Statistics, 
2016). In our data, the largest average in interval between first and last pregnancy 
was 7.6 years, therefore we could expect a maximum of 5% change in smoking 
behaviour of participants, which is not likely to have a major impact on our results. 
It is known that any active smoking during the reproductive period increases the 
risk of miscarriage (risk ratio of 1.23, 95%CI: 1.16, 1.30) with an additional increase 
when smoking is continued during pregnancy (risk ratio of 1.32, 95%CI: 1.21, 1.44) 
(Pineles et al., 2014). Although smoking during pregnancy has seen a steady year by 
year decline (HSCIC, 2014), very few women stop smoking before the development 
of the reproductive system of the embryo (Tong et al., 2013). This emphasizes that 
to decrease the risk of miscarriage is not to smoke at all, not only for the smoker’s 
own risk of miscarriage but also for the miscarriage risk of the next generation.
 Conclusion:
Our data showed a small but statistically significant increased risk of miscarriage 
for women who were exposed to cigarette smoke in-utero. The effect was stronger 
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when participants were current or previous smokers themselves or exposed to 
passive smoking. The effect was not present in participants who never smoked. 
This indicates that in-utero exposure may not be an independent factor for the risk 
of miscarriage, but a factor that modifies the effect of smoking of participants and 
passive smoking exposure.
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Objective: Cigarette smoking is a risk factor for earlier menopause. Animal studies 
show that in-utero smoke exposure is toxic to developing ovaries. Our aim was 
to evaluate whether in-utero smoke exposed women reach menopause earlier 
compared to non-exposed women. 
Methods: This is a cohort study within the Avon Longitudinal Study of Parents 
and Children (ALSPAC) in which pregnant women (participants) were followed 
from 1991/1992 until 2010. Participant characteristics for the current analysis 
were obtained from obstetric records and from annual follow-up questionnaires. 
When not available, age at natural menopause was estimated by age at filling in 
the questionnaire minus one year. Cox proportional hazards’ modelling was used 
to estimate hazard ratios of menopause for in-utero exposed and non-exposed 
participants. 
Results: There were 695/2852 postmenopausal participants, of whom 466 had 
natural menopause, 117 had hormonal therapy and 112 had surgical menopause. 
Age at natural menopause was 50.6±3.7 years. Of all participants, 20.2% (577/2852) 
were exposed to smoke in-utero. Participants who were in-utero exposed but were 
not smokers did not have higher hazards of menopause (adjusted HR 0.92, 95%CI 
0.72-1.18) while participants who were ever smokers (current or previous) and 
were in-utero exposed (adjusted HR 1.41 95%CI 1.01-1.95) or were ever smoker but 
not exposed (adjusted HR 1.24 95% CI 1.00-1.53) did. 
Conclusion: In-utero smoke exposure was not associated with earlier menopause 
but the effect of in-utero smoke exposure was modified by the smoking habits of the 
participants themselves increasing the risk for smoker who were in-utero exposed.





Menopause occurs when the ovarian follicle pool is depleted to a minimum 
threshold (Faddy and Gosden, 1996). The depletion of these follicles is a process 
that starts before birth and it continues until menopause (Coxworth and Hawkes, 
2010). The ovarian reserve, i.e. the population of non-growing follicles (NGF), is 
established prenatally; at 20 weeks post conception the population of NGF reaches 
a peak size (Mamsen et al., 2011) and some studies suggest that age at menopause 
is linked to the size of this initial cohort of NGF(Wallace and Kelsey, 2010; Depmann 
et al., 2015). Since this follicle pool is prenatally determined, early life events that 
are harmful to germ cells, can diminish the initial finite follicle pool a woman is born 
with(Richardson et al., 2014) and thus might influence timing of menopause. 
Women who are smokers reach menopause approximately one year earlier 
compared to non-smokers (Parente et al., 2008; Sun et al., 2012). Components of 
cigarette smoke, such as polycyclic aromatic hydrocarbons (PAH) and cadmium are 
involved in pathways leading to follicle loss, either via aryl hydrocarbon receptors 
in granulosa cells (Bussmann and Baranao, 2006) or via inhibition of gap-junctions 
of oocytes and granulosa cells (Gershon et al., 2008). Female germ cells are 
regarded to be especially vulnerable to cigarette smoke exposure during critical 
periods of primordial follicles development, when mitotic divisions of oogonia 
occur (Dechanet et al., 2011). Mice pups whose pregnant mothers were nasally 
exposed to mainstream cigarette smoke during pregnancy showed half the number 
of primordial and primary follicles when compared to controls(Camlin et al., 
2016). In human, 29 foetal ovaries obtained after legal abortions (aged 38-64 days 
post conception), in-utero smoke exposure was associated with a non-significant 
decrease in the number of oogonia (Lutterodt et al., 2009). These studies suggest 
that women who are in-utero exposed to cigarette smoke are born with a smaller 
ovarian reserve compared to non-exposed women, and therefore, might exhaust 
their follicle pool quicker, reaching menopause earlier. 
However, epidemiological studies have not indisputably confirmed nor rejected this 
hypothesis. Therefore, this study aimed to determine whether there is an association 
between in-utero smoke exposure and age at menopause in a longitudinal cohort of 
women whose menopause age was assessed 18 years after entry in the study. We 
have hypothesized that in-utero smoke exposed women reach menopause earlier 




This is a cohort study within the ongoing Avon Longitudinal Study of Parents and 
Children (ALSPAC) cohort, which was designed to identify environmental and 
genetic characteristics that can influence health and development in parents and 
children (Golding, 1990; Golding et al., 2001; Boyd et al., 2013). Pregnant women 
(participants) residents of the Avon County, UK, expected to deliver between 
April 1st 1991 and December 31st 1992 were included in the study. Participant’s 
characteristics for the current analyses were obtained from obstetrical records and 
from repeated annual follow-up questionnaires. Initially, 14,541 pregnant women 
(approximately 90% of pregnancies in the study area for enrolment period) were 
enrolled in the study. In 2010, 18 years after inclusion in the study, questionnaires 
were sent to 9028 participants who were still active in the cohort; 4175 (46.2%) 
of them returned the questionnaires and these participants were used in the 
current study. The main risk factor, in-utero smoke exposure, was obtained from 
questionnaires at baseline. Participants were asked “did your mother smoke?” and 
“did your mother smoke when pregnant of you (participant)?” and participants could 
answer in three different ways: “yes”, “no” and “I don’t know”. These questions 
were asked to participant again 8 years later. In order to evaluate misclassification 
and recall bias for in-utero smoke exposure, two analyses were performed. The first 
analysis evaluated whether in-utero smoke exposed participants were born with a 
lower birth weight compared to participants who were not exposed. The second 
analysis compared answers for in-utero smoke exposure given by the participants 
for two time points: at enrolment and 8 years later. Menopause status was obtained 
from questionnaires sent 18 years after baseline. Participants were asked: “in the 
last 12 months, have you had a period or menstrual bleeding?” and “what was your 
age at last menstrual bleeding? Please note that the study website contains details 
of all the data that is available through a fully searchable data dictionary available 
at http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary. Ethical 
approval for the study was obtained from the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees available at http://www.bristol.ac.uk/
alspac/researchers/research-ethics
Statistical analysis
Participants with inconsistent or missing information on age at surgery, start of 
HT (hormone therapy) use, or no age at oncological treatment (postmenopausal 
due to chemotherapy or radiotherapy) were excluded. Participants who reported 
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“other reasons” for menopause in the questionnaire were excluded. Participants 
with a history of ever using HT or having ovarian/uterine surgical removal before 
natural menopause were censored at the age of the event. Premenopausal women 
using HT were also censored at age when they started treatment. For participants 
who reported being postmenopausal but did not provide age at last menstrual 
bleeding, age at natural menopause was calculated from age at completion of the 
questionnaire minus one year.
Differences in characteristics of participants who were in-utero exposed and 
participants who were not exposed were tested using unpaired Student T-tests, 
Mann-Whitney or Chi-Square tests as appropriate. Cox proportional hazards 
modelling was used to estimate the crude and adjusted effect of in-utero smoke 
exposure on the age at menopause. Results were adjusted for factors associated 
with both in-utero smoke exposure and age at menopause. Factors that were 
different between groups but not associated with age at menopause were not 
included in the adjusted analyses. A hazard ratio (HR) higher than one indicates 
that in-utero smoke exposure is associated with a higher probability of reaching 
menopause compared to non-exposed during any given time period. Violation of 
the proportional hazards assumption was evaluated with Schoenfeld residuals test 
and the assumption was met (p-value= 0.40).
BMI included in the analyses was assessed at the enrolment period. Data analysed 
on participants smoking history included exposure by paternal and/or partner 
smoking and smoking of participants themselves. Smoking habits of participants 
were quantified by pack years using data from the follow-up questionnaires (18 
assessments in total). Exposure years were calculated by subtracting the age at the 
assessment point from the age when the participant started smoking. This number 
was multiplied by the number of cigarettes smoked per day divided by number of 
cigarettes per pack ([ age at assessment point-age started smoking]*[ number of 
cigarettes per day]/20). This was performed for each questionnaire interval and 
summed up. Participants were then categorized into heavy smokers (>25 pack 
years), moderate (>10 and ≤25 pack years), light (< 10 pack years) and non-smokers. 
At time point 18 years after enrolment, participants were asked if they are smokers. 
Those who answered “yes” were classified as current smokers. Previous smokers 
are the non-current smokers with pack years different than zero. Never smokers 
are participants with zero pack years. Ever smokers include participants who are 
current or previous smokers.
In order to verify a possible interaction between smoking habit of participants and 
in-utero smoke exposure, an interaction term was created with the product term 
from these two factors ( in-utero smoke exposure and smoking of participants 
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Figure I: Flow chart of participants.Footnote: Abbreviations: AAM age at menopause, HT 
(Hormone therapy). a. Inconsistencies are participants that had more than one answer to 
menopausal status. b.42 women were premenopausal and using HT. c. These participants 
are censored at the age they started using HT or age at surgery 
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themselves), including pack years as a continuous factor. The participants were then 
stratified into four groups: 1. exposed in-utero and ever smoker, 2. exposed in-utero 
and non-smoker, 3. not exposed in-utero and ever smoker and 4. not exposed in-
utero and non-smoker. The latter served as the reference group.
Results
From the questionnaires available, 4132/4175 participants provided information on 
menopause status. There were 7 participants missing data, 36 duplicates participants 
(twin pregnancies) and 3515 participants were eligible for analysis after exclusions 
(see figure I). Out of these, 663/3515 (18.9%) had missing information about in-
utero smoke exposure; 483/663 answered I don’t know” and 180/663 did not 
answer the question. There were 2157/2852 (75.6%) premenopausal participants 
and 695/2852 (24.4%) postmenopausal participants. Natural menopause was 
reported by 466/695 (67.1%) participants of which 359/466 (77.0%) did not 
provide age at menopause; 112/695 (16.1%) participants had surgical menopause 
and 117/695 (16.8%) participants used HT. Participants who reported menopause 
due to other reasons were excluded. Women with missing information on age at 
surgery and/or start of HT or, no age at oncological treatment (postmenopausal due 
to chemotherapy or radiotherapy) were excluded (see figure I).
For the participants who had surgery before menopause, 39 participants had 
hysterectomy and bilateral oophorectomy, 51 had hysterectomy, 6 had hysterectomy 
and unilateral oophorectomy, 2 had bilateral oophorectomy and 14 had unilateral 
oophorectomy. 
The kappa level of agreement comparing answers from in-utero smoke exposure for 
two time points (at enrolment and 8 years later, n=1032) was 0.91 (p-value 0.001) 
and there was a disagreement of 5% between answers.
Table I shows characteristics of the participants. Of all participants, 20.2% (577/2852) 
were smoke exposed in-utero and 79.8% (2775/2852) were not exposed. In-utero 
smoke exposed participants were born with a significant lower birth. Compared to 
participants who were not exposed, participants who were exposed in-utero were 
younger, had a higher BMI, were younger when they started using oral contraceptives 
(OC) and, when they had their first pregnancy. There were more current and 
previous smokers among exposed participants and there was higher passive smoke 
exposure due to smoking of fathers and partners. In-utero exposed participants also 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table II shows hazards ratios for menopause obtained from univariate analyses. A 
shorter cycle length, a younger age at start of OC, a younger age at first pregnancy, 
and having had ART were associated with earlier menopause. Being a smoker was 
associated with earlier menopause as were a younger age at start of smoking and 
being a heavy smoker. 
Analyses were adjusted for factors associated with both in-utero exposure and age at 
menopause (pack years, age at OC use start, age at first pregnancy and participant’s 
age). Pack years was removed from the adjusted model when other characteristics 
associated with active smoking of the participants were being analysed to avoid 
double correction for smoking factors. Please see supplementary table II for the 
comparison between crude and adjusted HR for menopause for all factors. There 
was a trend observed for the risk of menopause, with heavy smokers having the 
highest risk (HR 1.59 95%CI 1.13-2.25; adjusted HR 1.64 95%CI 1.16-2.33), followed 
by moderate smokers (HR 1.47 95%CI 1.15-1.87; adjusted HR 1.32 95%CI 1.02-1.70) 
and at last light smokers (HR 1.20 95%CI 1.00-1.45; adjusted 1.19 95%CI 0.98-1.45). 
Table II: Core covariates and their association with age at menopause of participants.
Footnote: a.information assessed at baseline time point
Crude HR, 95%CI p-value
Birth weight 1.00, 1.00-1.00 0.53
BMIa 1.01, 0.99-1.03 0.55
   Underweight 0.88, 0.70-1.13 0.32
   Normal reference
   Overweight 1.09, 0.90-1.32 0.36
   Obese 1.06, 0.76-1.47 0.74
Age at menarche 0.97, 0.92-1.01 0.15
   8-11 years 1.15, 0.96-1.38 0.13
   12-14 reference
   15 or more 0.94, 0.77-1.16 0.56
Regular menstrual periodsa
   Yes reference
   No 0.92, 0.78-1.09 0.35
Cycle length (days)a 0.96, 0.94-0.98 <0.001
   20 or less 2.09, 1.04-4.21 0.04
   21-35 reference
   36 or more 0.47, 0.06-3.36 0.45
Ever used OC 0.89, 0.69-1.15 0.37
Age 1st used OC 0.95, 0.93-0.98 <0.001
105
6
Ever seen a doctor for possible infertility 1.19, 1.00-1.41 0.05
Age at 1st pregnancy 0.98, 0.97-0.99 <0.001
Parity
   1 1.04, 0.90-1.20 0.62
   2 or more reference 
Ever had ART treatment 1.37, 1.03-1.83 0.03
Active smoking 
  Current 1.45, 1.20-1.86 <0.001
  Previous 1.22, 1.02-1.46 0.03
  Never reference
Age started smoking 0.95, 0.92-0.99 0.01
Pack years 1.02, 1.01-1.03 <0.001
  Heavy smoker 1.59, 1.13-2.25 0.01
  Moderate smoker 1.47, 1.15-1.87 0.02
  Light smoker 1.20, 1.00-1.45 0.05
  Non-smoker reference
Passive smoking
  Participant’s father smoker 1.12, 0.96-1.31 0.15
  Participant’s partner smoker 1.14, 0.98-1.32 0.09
Table III shows crude and adjusted HR for participants who were in-utero exposure, 
ever smokers and, for stratified groups of in-utero exposure and ever smoking 
combined. In-utero smoke exposure was not associated with earlier menopause. 
There an interaction between in-utero smoke exposure and pack years of participants 
(p=0.02). The stratified analysis confirmed a stronger effect of ever smoking and in-
utero exposure on age at menopause, i.e. smokers who had been exposed in-utero 
had higher risk when compared to smokers or smokers who were not exposed. 
Sensitivity analysis with participants with available age at menopause only did 
not change the results (HR 0.98, 0.75-1.29; adjusted HR 0.97, 0.73-1.29, see 
supplementary table I).
Participants were not included in the analyses for two reasons: missing data on in-
utero exposure (n=663) and excluded participants due to other reasons (n=617). 
There were no statistically significant differences regarding smoking status between 
participants who had available (26.2%, 746/2852) and those who had missing data 
(28.2%, 187/663) regarding in-utero exposure (p-value= 0.49). For the group who 
was excluded for other reasons, smoking status was slightly higher (31.9%, 197/617 

































































































































































































































































































































































































































































(24.6%, 122/495 versus 20.2%, 577/2852, p-value= 0.03). Analysis including these 
participants (n=3347) showed no substantial difference (OR 0.91, 95%CI 0.76-1.08, 
adjusted OR 0.86, 95% CI 0.70-1.04) compared to the analysis excluding this group 
(table III).
Discussion
Results from the present study indicate that in-utero smoke exposure is not 
associated with earlier age at menopause. There was an interaction between pack 
years of participants and in-utero smoke exposure, i.e. the effect of in-utero smoke 
exposure was modified by the smoking habits of the participants themselves.
Strengths of this study are the large number of participants and the substantial 
proportion of postmenopausal women. Moreover, the 18-year follow up, the 
availability of repeated questionnaires and information regarding various factors 
relevant for the risk of menopause are strong points. This allowed the calculation of 
pack years for participants who were ever smokers, so that the confounding effect 
of smoking of participants could be analysed in a dose-response manner. 
Although there is no previous data available reporting the accuracy of in-utero 
smoke exposure based on questionnaires, in this data participants who reported 
being in-utero smoke exposed had a lower birth weight and the agreement between 
questionnaire from two different time points were satisfactory. This indicates low 
misclassification and recall bias.
Limitations included no information about the number of cigarettes smoked by 
the mothers while they were pregnant with the participants, no information about 
trimester of exposure and, incomplete information on age at menopause. Higher 
levels of in-utero smoke exposure could have an effect on age at menopause, similar 
to the dose effect relationship observed for the smoking habits during adulthood. 
Given the time period during which these pregnancies occurred, i.e. around the 
mid-1960’s, we assumed mothers of the participants would have smoked during 
the entire pregnancy. Smoking was widely accepted in this period(Pierce et al., 
1994) and the effects of smoking during pregnancy were not widely known(DOLL 
and HILL, 1950). 
In the current study, we had to estimate age at menopause by subtracting one 
year of the questionnaire’s age at completion for 51.7% (359/695) of participants 
who reported they were postmenopausal. This may have resulted in shifting age 
at menopause to a later age for women who went into menopause more than one 
year before completion of the questionnaire. Nevertheless, analysis including only 
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participants with available age at menopause showed a similar effect compared to 
the analysis including women whose age at menopause was estimated.
The long follow-up period resulted in a dropout rate of 38% (14541-9028/14541) 
and there was a response rate of 46.2% (4175/9028), when considering participants 
who were still active in the cohort. Therefore, our results are based on 20% 
(2852/15541) of the original data, from which results cannot be extended and as 
consequence we cannot exclude the risk of selection bias (Fraser et al., 2013). 
Participants in this study were pregnant when they were recruited. Therefore, 
results cannot be readily extended to nulliparous women. Our hypothesis, that in-
utero exposed women have higher hazards of menopause, was not confirmed by 
our results. Previous studies have shown results both similar and dissimilar to ours, 
and the method of analysis may have played a role in this. Results similar to ours 
were observed in a large dataset (n=22165), with 30% postmenopausal participants 
and 36% in-utero exposure(Steiner et al., 2010). The authors censored participants 
who were postmenopausal due to surgery, just as we have done in our analysis, and 
found that in-utero exposure was not associated with earlier menopause (HR 1.02 
95%CI 0.97-1.7). Another study (n=4025) with 37.0% postmenopausal participants 
and 14.8% in-utero exposure, has shown an effect on age at menopause (HR 
1.21 95% CI 1.02-1.43) (Strohsnitter et al., 2008). In this study, in-utero exposed 
women who did not smoke had higher hazards of menopause (1.38 95%CI 1.10-
1.74) compared to the smokers (1.03 95%CI 0.81-1.31). However, this study was 
performed in a cohort in which 80% of the women were prenatally exposed to 
diethylstilboestrol (DES). DES is known for its reductive influence on development 
competence of primordial follicles(Grive and Freiman, 2015). Therefore, these 
results might be limited to this specific prenatal DES-exposed population.
In the study of Tawfik and colleagues, 1001 women were analysed, of whom 3.8% 
were postmenopausal and 40% were exposure in-utero (Tawfik et al., 2015). The 
authors used logistic regression instead of Cox regression, differently from the 
other studies previously described above. Smoking participants who were exposed 
in-utero had the highest odds of menopause (OR 3.4, 95% CI 1.1-10.3), followed 
by smokers who were not exposed in (OR 2.8 95% CI 0.9-9.0). In their analyses, 
the authors controlled for age of the participants and, since censoring was not an 
option with the logistic regression model, they excluded women who used HT or 
had ovarian or uterine surgery. When we repeated their analyses in our data, we 
found similar results to theirs which were in the same direction and with higher 
estimates (OR 2.23, 95% CI 1.25-3.97; OR 1.74, 95% CI 1.21-2.49, respectively) 
compared to the analysis with Cox regression including HT and participants who 
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had surgery . With the exclusion of these women from our data, the estimates 
with Cox regression were also slightly increased (HR 1.55, 95%CI 1.01-2.36 and HR 
1.37, 95%CI 1.06-1.77).. Our conclusion is based on the analysis with Cox regression 
censoring participants who used HT or who had surgery since this is the most 
appropriate method to avoid bias in Cox Regression analysis(van Walraven and 
Hawken, 2016). When censoring, the analysis takes into consideration that up to 
the point that participants started using HT or had surgery, participants were still 
premenopausal and that is important information to include in the analysis. We 
consider that excluding these women introduces bias, resulting in overestimation 
of the risk.
Despite the negative effect that smoking has on age at menopause for smokers 
themselves, the same effect was not observed for women who were only in-utero 
exposed. One explanation for this may be the strongly programmed mechanism 
that determines age at menopause. This evidence comes from studies in which 
women who had unilateral oophorectomy, despite losing half of their ovarian 
reserve, reached menopause only one year earlier (Yasui et al., 2012; Bjelland et al., 
2014). Some studies suggest compensatory growth of the remaining ovary (Roth 
and Jones, 1992) This indicates that there could be other determinants for the onset 
of menopause additionally to the size of the follicle pool. Van Asselt and colleagues 
argue that the capacity of remaining follicles to produce oestrogens can be relevant 
as well for onset of menopause (van Asselt et al., 2004). Another explanation might 
be the existence of counterbalancing protective mechanisms such as recruitment in 
wave-like fashion of less oocytes per cycles (Baerwald et al., 2003) or longer cycle 
lengths so that the total number of ovulation in a lifetime is shortened (Cramer 
et al., 1994), supported by studies that showed an earlier age at menopause for 
mothers of dizygotic twins compared to control mothers (Martin et al., 1997; der 
Stroom et al., 2013). Germline stem cells in adult human ovaries, which could be 
activated postnatally under specific circumstances (Tilly and Telfer, 2009) could be 
another possibility but robust human data is necessary to support this hypothesis 
(Johnson et al., 2004; Hikabe et al., 2016). 
Conclusions 
Our results indicate that in-utero smoke exposure is not associated with earlier 
menopause, though smoking of participants is. There was an interaction observed 
between in-utero smoke exposure and pack years of participants, i.e., the effect of 
in-utero smoke exposure was modified by the smoking habits of the participants 
themselves. Despite the effect of adult active smoking on age at menopause and 
the significant reduction of the follicle pool associated with in-utero smoke exposure 
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shown in experimental studies, our epidemiological study does not support similar 
mechanisms for in-utero exposed women who are not smokers themselves. 
Counterbalancing protective mechanisms may play an important role in order to 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We are extremely grateful to all the families who took part in this study, the 
midwives for their help in recruiting them, and the whole ALSPAC team, which 
includes interviewers, computer and laboratory technicians, clerical workers, 
research scientists, volunteers, managers, receptionists and nurses. The UK Medical 
Research Council and Welcome (Grant ref: 102215/2/13/2) and the University of 
Bristol provide core support for ALSPAC. This publication is the work of the authors 
and will serve as guarantors for the contents of this paper. This research was 
specifically funded by the Department of Obstetrics and Gynaecology, UMCG.
Financial support: Department of Obstetrics and Gynaecology, section of 
Reproductive Medicine, University Medical Centre Groningen.
Conflict of interest: Outside the submitted work, the Fertility Centre of the UMCG 
received an unrestricted educational grant from Ferring pharmaceuticals BV, The 
Netherlands.
Chapter 7 
Summary, general discussion and future perspectives
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The aim of this thesis is to determine whether there is an association between 
diminished ovarian reserve and adverse reproductive outcomes or reproductive 
lifespan (menopause). The association between quantity and quality of oocytes is 
important to be established since women are trying to conceive at a later age, when 
the ovarian reserve is diminished to a level in which there are higher chances of 
adverse reproductive outcomes. The risks of the most common adverse pregnancy 
outcomes likely to occur in women who postpone childbearing were tested in the 
general and IVF-treated populations. 
7.1 Summary of the findings
Chapter 2 describes a matched case-control study based on national Danish health 
registry data. The study investigated whether women with a history of ovarian 
surgery, as a proxy for diminished ovarian reserve, had a higher risk of a trisomic 
pregnancy. Cases were women with a confirmed trisomic pregnancy occurring 
between January 1st 2000 and December 31st 2010 and controls were women 
with a live born child without a trisomy. In total, 1723 cases and 6850 age-matched 
controls were included in the study. A history of ovarian surgery was present in 
2.7% (46/1723) of the cases versus 2.5% (172/6850) of the controls and was not 
associated with a higher risk for a subsequent trisomic pregnancy (OR 1.00, 95% CI 
0.99-1.01). Subgroup analyses by indication of ovarian surgery and interval between 
ovarian surgery and pregnancy did not change the results.
Chapter 3 describes an age-matched case-control study investigating the risk of 
a trisomic pregnancy in relation to oocyte yield in IVF-treatment. The proxy for 
diminished ovarian reserve in this study was low oocyte yield (three or less oocytes 
retrieved after controlled ovarian stimulation). Cases were women with a trisomic 
pregnancy (trisomies 13, 18 or 21) resulting from fresh IVF treatment and confirmed 
by karyotyping. Controls were age-matched women with a live born child without 
a trisomy. Analyses were performed in 103 cases and 432 controls from Dutch 
and Danish national cohorts containing data obtained from IVF registries from 
1983 to 2010. Low oocyte yield was observed in 6.5% (28/428) of the women, of 
whom 8.6% (7/81) were cases and 6.1% (21/347) were controls. Low oocyte yield 
was not associated with a higher risk of trisomic pregnancy (OR 1.2, 95% CI 0.8-
1.9). Stratification for female age, adjustment for history of ovarian surgery and 
stimulation protocol used did not change the results.
Chapter 4 is a cohort study aimed to determine whether diminished ovarian 
reserve, reflected by repeated low oocyte yield in IVF-treatment, is associated with 
miscarriage. We included 933 Dutch IVF patients who had their first two IVF cycles 
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within one year and conceived after the second cycle. Patients were selected from 
a national Dutch IVF registry from 1983 to 1995. The proxy for diminished ovarian 
reserve in this study was the retrieval of three or less oocytes in both the first and 
second IVF cycle, i.e. a repeated cycles with low oocyte yield. Women achieving 
an ongoing pregnancy (viable intra-uterine pregnancy ≥ 16 weeks) were compared 
to those experiencing a miscarriage (pregnancy loss between 4-16 weeks). We 
analysed miscarriage risk in women with twice (4.6%), once (16.9%), and no (78.4%) 
cycle with low oocyte yield. Women with two cycles with low oocyte yield more 
often experienced miscarriage (37.2%) compared to women without low oocyte 
yield (18.7%) (crude OR 2.57, 95%CI 1.35-4.91; adjusted for female age OR 2.21, 
95%CI 1.14-4.28). Women with one cycle with low oocyte yield did not have an 
increased risk of miscarriage (20.9%) compared to women without low oocyte yield, 
irrespective of whether low oocyte yield occurred in the first or second IVF cycle.
Chapter 5 is a cohort study including 7160 participants from the British ALSPAC study, 
a cohort in which women from the Avon County were included and followed-up. 
The proxy for diminished ovarian reserve in the study was in-utero cigarette smoke 
exposure of the participants. The adverse reproductive outcome was miscarriage, 
defined as a pregnancy loss after 20 weeks gestation or less. We used obstetric history 
data, obtained from medical records and questionnaires, regarding pregnancies 
occurring before inclusion of participants in the cohort in 1992. Participants who 
were exposed to cigarette smoke in-utero (n= 2049/7160, 28.6%) had a higher risk 
of ever having a miscarriage (33.7% versus 30.9%; adjusted OR 1.12, 95%CI: 1.00, 
1.27) compared with participants who were not exposed. The risk of one previous 
miscarriage was not influenced by being in-utero exposed (OR 1.08, 95%CI: 0.95, 
1.23). However, the risk of having two (OR 1.30, 95%CI: 1.02, 1.67) or three or more 
(OR 1.17, 95%CI: 0.80, 1.69) previous miscarriages was higher for participants who 
were exposed in-utero. There was an interaction between in-utero smoke exposure 
and three factors: packyears of the participants (i.e. the smoking behaviour of the 
participants themselves), passive smoke exposure from other household members, 
and age at first and last pregnancy of the participants. Participants exposed in-utero 
who were ever smokers themselves had an increased risk of miscarriage (OR 1.26, 
95% CI: 1.11, 1.52) while participants exposed in-utero who were never smokers did 
not (OR 0.93, 95% CI: 0.78, 1.12).
Chapter 6 is also a cohort study within the ALSPAC cohort aimed to evaluate 
whether women exposed to cigarette smoke in-utero reach menopause earlier 
compared to non-exposed women. Women who were still active participants in 
the ALSPAC cohort in 2010, i.e. 18 years after enrolment period, were eligible 
for this study. There were 2852 participants eligible for analysis, of which 24.4% 
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(695/2852) were postmenopausal. Of all participants, 20.2% (577/2852) were 
exposed to cigarette smoke in-utero. In-utero smoke exposure was not associated 
with earlier menopause. Participants who were in-utero exposed but were not 
smokers themselves did not have higher hazards of menopause (adjusted HR 0.92, 
95%CI 0.72-1.18), while participants who were ever smokers (current or previous) 
did, whether they were in-utero exposed (adjusted HR 1.41 95%CI 1.01-1.95) or not 
(adjusted HR 1.24 95% CI 1.00-1.53).
Figure 7.1: Summary of the findings in this thesis concerning an association between 
diminished ovarian reserve and adverse reproductive outcome
7.2 Discussion of the results of this thesis and studies 
available in the literature
In this thesis, ovarian surgery, low oocyte yield in IVF with controlled ovarian 
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stimulation and in-utero cigarette smoke exposure were taken as proxies for 
diminished ovarian reserve. Our results indicate that repeated low oocyte yield, 
defined as three or less oocytes retrieved in IVF treatment, and in-utero cigarette 
smoke exposure are associated with miscarriage (see figure 7.1). Moreover, smoking 
women who are exposed to cigarette smoke in-utero have a higher risk of earlier 
menopause.
7.2.1 Ovarian surgery as proxy for diminished ovarian reserve
Ovarian surgery was not associated with an increased risk of a trisomic pregnancy in 
our study, which contradicts two previous studies (OR for trisomic pregnancy 9.61, 
95%CI 1.18-446.3) (Freeman et al., 2000) and (OR for trisomic pregnancy 3.3, 95% 
CI 1.0-10.5) (Haadsma et al., 2010b). These studies have smaller sample sizes and 
larger confidence intervals compared to the study in this thesis. 
The effect of the reduction of ovarian reserve after ovarian surgery is demonstrated 
by studies showing an earlier menopause for women with unilateral oophorectomy 
(Cramer et al., 1995; Yasui et al., 2012; Bjelland et al., 2014) compared to women 
with both ovaries and studies showing a reduction in the results of ovarian reserve 
tests (ORTs) for women who had part of their ovarian tissue removed, for example, 
after excision of endometrioma (Almog et al., 2010). 
However, systematic reviews evaluating the effect of surgery on ORTs are conflicting 
(Raffi et al., 2012; Somigliana et al., 2012; Muzii et al., 2014; Cagnacci et al., 2016).
These may be explained by the fact that, first, the results of ORTs might be low already 
prior to surgery, due to the underlying pathology, such as endometriosis (Muzii 
and Miller, 2011; Lind et al., 2015). Second, the interval between surgery and ORTs 
assessments might have been different between studies and this interval seems to 
be important. ORTs seem to show lowest values immediately after surgery (kitajima 
et al., 2011), but exhibit partial recovery in longer follow-up assessments (Chang et 
al., 2010; Zhai et al., 2012; Sugita et al., 2013). It is hypothesized that this recovery 
can be caused by a compensatory mechanism of the remaining ovarian tissue. This 
may also be the explanation for the fact that women with previous oophorectomy 
have, on average, age at menopause only one year earlier, which is not proportional 
to the amount of ovarian tissue lost (Cramer et al., 1995; Yasui et al., 2012; Bjelland 
et al., 2014). In mice, after the removal of one ovary, the remaining ovary showed 
increased ovarian weight due to hypertrophy and increased formation of corpus 
luteum 19-21 days after surgery (Bhattacharya, 2013), but no changes in the number 
of primordial follicles after surgery (Aydin et al., 2010). In addition, although women 
with a single ovary have a lower response to ovarian stimulation (Lass et al., 1997b; 
Almog et al., 2010) and may need higher gonadotropin dosages (Lass et al., 1997b) 
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it was shown that the oocyte yield per ovary was higher in women with a previous 
oophorectomy compared to women with both ovaries in situ (Khan et al., 2014). 
These findings indicate that the loss of ovarian reserve after surgery is at least partly 
compensated by optimized use and function of the remaining ovarian tissue. One 
suggested mechanism is the fact that ovarian surgery may induce fragmentation of 
the cortex of the ovary. Ovarian fragmentation seems to waken dormant follicles via 
growth factors activated by the so called PTEN (phosphatase with tensin homology 
deleted in chromosome 10) inhibitor and PI3 kinase (phosphatidyinositol-3-kinase) 
stimulator(Hsueh et al., 2015). Ovarian fragmentation is being explored as a possible 
approach for infertility treatment (Kawamura et al., 2013; Suzuki et al., 2015). Other 
mechanisms could be the decrease of follicular atresia of FSH dependent follicles, 
possibly as a consequence of higher gonadotropin levels after oophorectomy and/
or an increase in the recruitment or transition of the NGF (non-growing follicles) 
into the FSH dependent follicle pool .
Ovarian surgery thus diminishes ovarian reserve via the direct mechanical removal 
of ovarian tissue, specifically when it involves the ovarian cortex, where the 
majority of the NGFs are located, but the effect of this reduction might mainly be 
temporary due to compensatory mechanisms. However, there is no strong evidence 
of lower quality of the oocytes as a result of ovarian surgery. In our study we could 
not confirm the limited pool hypothesis for the association between reduced 
oocyte quantity resulting from ovarian surgery and oocyte quality, using trisomic 
pregnancy as a proxy. 
In support of our findings, embryo quality does not seem to differ (Harada et al., 
2015) and live birth rates are similar in women with one ovary as compared to women 
with both ovaries (Lass et al., 1997a; Khan et al., 2014). Additionally, no difference 
was found in miscarriage rates between women who had unilateral ovariectomy 
(28.5%), and controls with cholecystectomy (30.8%) and appendectomy ( 28.2%) 
(Bellati et al., 2014). Therefore, we suggest that ovarian surgery has an effect on 
quantity, but not on quality of the oocytes.
Conclusion: Ovarian surgery, as a proxy for diminished ovarian reserve, has a 
negative effect on quantity of ovarian reserve, but this effect may be largely 
temporary. The adverse reproductive outcomes associated with ovarian surgery are 
likely to be restricted to outcomes associated with the quantity of follicle pool, such 
as earlier menopause, and not quality, such as trisomic pregnancy or miscarriage. 
Clinical implications: Women with a history of ovarian surgery prior to pregnancy 
may not be regarded to be at a higher risk for a trisomic pregnancy or miscarriage. 
In case these women need IVF treatment, higher dosages of ovarian stimulation 
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may be needed, and a lower oocyte yield might be anticipated. Their embryos are 
not likely to have lower quality, and the chances of live birth are similar to women 
with two ovaries. However, these women need to be aware that their reproductive 
lifespan might be in average, one year shorter. That needs to be taken into 
consideration when planning when to start a family.
7.2.2 Low oocyte yield as proxy for diminished ovarian 
reserve
Low oocyte yield in IVF treatment was not associated with a higher risk of having 
a trisomic pregnancy in our study. This finding differs from a previous study from 
our research group (Haadsma et al., 2010b), in which the odds for a trisomic 
pregnancy for women with three or less oocytes retrieved was around three times 
higher compared to women with normal response (OR for trisomic pregnancy for 
women with three or less oocytes retrieved 2.72, 95% CI 0.69-10.69) (Haadsma et 
al., 2010b). This difference in results is attributed to differences in study population 
and statistical analyses. The data from the Haadsma et al. study were re-analysed 
with the statistical techniques used in the study in this thesis, and the differences 
were no longer present. We concluded that the results of the previous study are 
likely to show an overestimation of the effect.
Within the same patient, the number of recruited follicles differs per cycle (Elter et 
al., 2005; van Disseldorp et al., 2010). A low oocyte yield after controlled ovarian 
stimulation might be the result of this inter-cycle variability or may result from 
underdosage of gonadotropins. In this situation, there is no diminished ovarian 
reserve: a sufficient total number of follicles is available, but only a few are recruited 
in that particular cycle. A different situation is when the number of follicles is actually 
diminished, in which no matter the stimulation dosage, type or cycle number, the 
response will always be low. A second cycle with low oocyte yield occurs in 36% 
of women who had a previous cycle with low oocyte yield (Klinkert et al., 2004). 
Therefore, the majority of women with a low oocyte yield after controlled ovarian 
stimulation might not have a diminished ovarian reserve.
Two consecutive cycles of low oocyte yield (or more) is a condition in which the 
patient is called a “poor responder”. In addition to two cycles of low oocyte yield , 
the Bologna criteria define a “poor responder” as a patient with at least two of the 
following criteria: (a) age > 40 years, (b) previous cycle with a low oocyte yield or 
(c) abnormal ovarian ORTs (AMH < 0.5-1.1 ng/ml or AFC < 5-7 follicles) (Ferraretti 
et al., 2011). Therefore, being a “poor responder” is likely to be a better proxy 
for diminished ovarian reserve than one cycle of low oocyte yield alone. In this 
thesis, women with two consecutive cycles of low oocyte yield were at a higher 
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risk for miscarriage, one of the adverse outcomes presumably resulting from low 
oocyte quality. A single response of three or less oocytes after controlled ovarian 
stimulation is not necessarily associated with poor outcomes such as lower embryo 
quality or lower live birth rates (Arce et al., 2014; Mustafa et al., 2017). But a low 
oocyte yield, in women fulfilling the Bologna criteria for “poor responders” is more 
indicative of poor prognosis (Busnelli et al., 2015; Marca et al., 2015). Live birth 
rates for “poor responders” are expected to be as low as 6-10% (Polyzos et al., 2014; 
Busnelli et al., 2015; Marca et al., 2015).
Being a poor responder might well be a condition in which the quantity and quality 
of the ovarian reserve are associated.
The literature indicates that one cycle of low oocyte yield is associated with earlier 
menopause (de Boer et al., 2003; Lawson et al., 2003; Szmidt et al., 2016) and 
there are studies indicating an association between one cycle of low oocyte yield 
and adverse reproductive outcomes (Haadsma et al., 2010a; Sunkara et al., 2014). 
This effect might be related to the “poor responders” included within these groups 
of women with low oocyte yield. This might be particularly true when the cut-off 
for low oocyte yield is set at three oocytes or less. Once the cut-off is elevated, 
e.g. to five oocytes or less, the proportion of “poor responders” within the group 
of women with low oocyte yield decreases, and the effect of low oocyte yield on 
adverse reproductive outcome is no longer observed (Kumbak et al., 2009; Setti et 
al., 2011). 
Conclusion: The effect of low oocyte yield as a proxy for diminished ovarian reserve 
is not straightforward because of the “false positives” included in that group, i.e., 
women with a normal ovarian reserve experiencing a random low oocyte yield. While 
there was no effect of one cycle of low oocyte yield on trisomic pregnancy risk, once 
the proxy was a “poor responder”, defined as women with two consecutive cycles 
of low oocyte yield, we observed a higher risk for miscarriage. Women who are 
“poor responders” are the ones at higher risk for adverse reproductive outcomes. 
Thus, being a “poor responder” is a condition in which the quantity and quality of 
the oocytes are associated. 
Clinical implications: A low oocyte yield in a first cycle should be interpreted with 
caution. Low oocyte yield is not necessarily associated with a diminished ovarian 
reserve. After a first cycle with low oocyte yield, patients should be evaluated 
using the Bologna criteria. If they fulfil the criteria, they should be counselled of a 
poor prognosis for a live birth. Women achieving a live birth after being diagnosed 
as a “poor responder”, she should be counselled in case there is a desire for 
another pregnancy, that the interval between pregnancies should be the shortest 
appropriate interval in order to minimize the effects of further decline of ovarian 
reserve, quantitatively and qualitatively with time. 
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7.2.3 In-utero cigarette smoke exposure as proxy for 
diminished ovarian reserve
In-utero cigarette smoke exposure, as a proxy for diminished ovarian reserve, 
was associated with a higher risk of having a miscarriage in our study. This is in 
accordance with the results from Cupul-Uicab and colleagues (Cupul-Uicab et al., 
2011), the only other study available on this subject. This is suggestive that cigarette 
smoke exposure in-utero has an effect on the quality of the foetal oocytes.
With respect to the quantity of ovarian follicles, animal studies showed a decreased 
number of primordial and primary follicles and ovarian volume in mice exposed to 
cigarette smoke in-utero (Sobinoff et al., 2013; Camlin et al., 2016). The only human 
study with foetal ovaries showed a decreased number of oogonias in foetuses who 
were in-utero exposed to cigarette smoke (Lutterodt et al., 2009). So indeed, in-
utero cigarette smoke exposure leads to a lower ovarian reserve early in life.
With respect to quality of ovarian follicles, meiotic errors due to alterations in 
spindle formation were observed in mice exposed to cigarette smoke in-utero 
(Camlin et al., 2017). These alterations are associated with aneuploidies in 
oocytes (Eichenlaub-Ritter, 2012)leading to higher risk of trisomic pregnancy and 
miscarriage. Summarizing, these studies show that cigarette smoke exposure in-
utero has an effect on ovarian reserve both quantitatively and qualitatively.
However, in-utero cigarette smoke exposure, as a proxy for diminished ovarian 
reserve, was not associated with a higher risk of having an earlier menopause in 
our study. There are three previous studies on this same issue but with conflicting 
results (Strohsnitter et al., 2008; Steiner et al., 2010; Tawfik et al., 2015). The 
strongest evidence, from the study of Steiner and colleagues, with a large sample 
size (n=22165) and appropriate statistical method to analyse the research question 
(Steiner et al., 2010), suggests that there is no effect of in-utero smoke exposure 
on age at menopause. Therefore, in-utero cigarette smoke exposure may not be a 
proper proxy for diminished ovarian reserve and seems to have an effect on oocyte 
quality but not on quantity.
This is an opposite conclusion from the effect of ovarian surgery, in which there 
seems to be no effect on oocyte quality, but which does affect oocyte quantity, 
though less than expected, probably mediated by compensatory mechanisms. 
These compensatory mechanisms, however, might be a general response to ovarian 
insult, and it could also explain the lack of difference in age at menopause for 
women who were exposed in-utero and those who were not. Putatively, the less 
ovarian tissue a woman has, the more efficient the compensatory mechanism to 
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spare unnecessary follicle loss might be. The pathway however, might be different.
In this thesis cigarette smoke exposure in-utero alone had no effect on age at 
menopause, but there was an interaction cigarette smoking later in life: women 
who were smokers themselves and had been exposed in-utero did have earlier 
menopause, which was also observed in a previous study (Tawfik et al., 2015). The 
same interaction was observed when miscarriage was the adverse outcome, i.e. 
miscarriage risk was increased for women who were smokers and had been exposed 
to cigarette smoke in-utero. Possibly, the compensating mechanisms of the ovary 
fail when being hit with the toxic effects of smoking twice. First in-utero, leaving the 
ovaries with less and arguably partly damaged oocytes to start out with, and second 
when the woman starts smoking herself. But exactly what occurs to the dynamics of 
ovarian, follicle recruitment and follicle loss once there is a disturbance early in life 
to explain this interaction is not clear. The increased miscarriage risk that smoking 
women face is not likely to be caused by an increase in aneuploidies; many studies 
indicate that trisomic pregnancies are not associated maternal smoking (Rudnicka et 
al., 2002). There is, however, a gap in the literature with respect to cigarette smoke 
exposure in-utero and a higher chance of having a trisomic pregnancy later in life. It 
is perceivable that the toxic effects of smoking on the developing human ovary in-
utero may differ from the effects of smoking of the woman herself when her ovaries 
are full-grown. A higher chance of trisomic pregnancies was indeed established in 
mice after in-utero smoke exposure. However, a note of caution is necessary for the 
direct translation of the results to humans since the foetal ovarian development in 
humans differs from that in mice. Unlike in humans, in mice, the development of 
primordial follicles proceeds after birth (Chadio and Kotsampasi, 2014)
Conclusion: Cigarette smoke exposure in-utero, as a proxy for diminished ovarian 
reserve, seems to be associated with diminished quality of the oocytes, leading to 
an increased miscarriage risk later in life. However, we don’t know whether cigarette 
smoke exposure in-utero is actually an optimal proxy for a decrease in quantity, as 
menopausal age is not affected. Thus, the relation between quantity and quality 
cannot be confirmed in the studies in this thesis.
Clinical implications: Smoking during pregnancy affects the reproductive capacity in 
two generations. The reproductive lifespan of the daughters might not be affected, 
but there is an increased risk of miscarriage for in-utero exposed daughters later in 
life. This is another strong argument, on top of many others, not to smoke, especially 
in the preconception period.
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7.3 General conclusion- diminished ovarian reserve and 
adverse reproductive outcomes
Diminished ovarian reserve is a result of various mechanisms leading to a decrease 
in the quantity of the oocytes. First of all, diminished ovarian reserve is caused by the 
physiological effects of ageing. This results in both a decline in quantity and quality 
of the oocytes; two processes that seem highly correlated. The Bologna criteria for 
“poor responders”, also used in this thesis, show parallels with diminished ovarian 
reserve as caused by age, i.e., both quantity and quality of oocytes are affected 
and related. Differently, and with opposite effects in the outcomes described in 
this thesis and related literature, ovarian surgery showed an effect on quantity of 
oocytes only, without effect on oocyte quality and cigarette smoke exposure in-
utero showed an effect on quality of the remaining oocytes only, without effect on 
menopausal age. 
There is no consensus in the literature on the definition of diminished ovarian 
reserve, neither on which of its features are associated with adverse reproductive 
outcomes (Cohen et al., 2015). This thesis suggests that the underlying mechanism 
leading to a diminished ovarian reserve will determine whether there is a clinical 
detectable association between oocyte quantity and quality, reflected by adverse 
reproductive outcomes. Moreover, little is known about the presumed compensatory 
mechanisms within the ovary that might add to the effects. 
7.4 Reflections on the use of epidemiological studies
This thesis explored a possible association between diminished ovarian reserve and 
adverse reproductive outcomes via epidemiological retrospective observational and 
case-control studies. Recall bias and misclassification bias are limitations for these 
types of studies. When possible, we tried to reduce the possibility of these kinds 
of bias by using and analysing repeated questions in questionnaires and comparing 
the information from medical files. We dealt with missing data properly in order 
to diminished the chances of biased results. We performed sensitivity analyses in 
the various studies to evaluate the effect of groups excluded from the analysis or 
specific groups within the data. 
The major confounder in all our studies is age and was addressed properly by 
analysis with adjustment for age, stratification and matching by age. However, 
the best statistical methods will never be able to overcome the limitations of 
using proxies. Ovarian reserve cannot be studied in vivo. We used proxies for the 
association between oocyte quantity and oocyte quality. Perfect biological markers 
for ovarian reserve and oocyte quality do not exist. The limitations of our proxies 
for low oocyte quantity are discussed above. In addition, not all miscarriages and 
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trisomic pregnancies are the result of poor oocyte quality (Hunt and Hassold, 2010; 
Nagaoka et al., 2012; Jia et al., 2015) . However, when oocyte quality is affected, 
these adverse reproductive events are most prevalent clinically relevant and 
detectable outcomes.
7.5 Future perspectives
We used epidemiological studies to assess the underlying relations and conclude 
that, putatively, the underlying mechanisms leading to a diminished ovarian reserve 
are associated with various adverse outcomes. 
We observed a gap in the literature concerning cigarette smoke exposure in-utero 
and adverse reproductive outcomes, such as trisomic pregnancies, congenital 
anomalies, but also fertility of the daughters and sons. With big data and birth 
records becoming more common, such studies become feasible and they should be 
less complicated to design. Another question regarding cigarette smoke exposure 
in-utero is the possibility of an effect on the grandchildren of the smoking mothers, 
since the grandchildren are already present as gametes in-utero, including their 
reproductive potential. 
Future studies should consider the mechanisms underlying diminished ovarian 
reserve in order to hypothesize for an existing association with quality. 
Basic research is necessary to explore the various underlying biological mechanisms 
leading to the decline in the ovarian follicle pool and decrease in oocyte quality. 
In general, relatively little is known about the dynamics of follicle atresia and 
recruitment. Concerning oocyte quality, studies on important regulatory role of 
mitochondria in oocytes, but also the surrounding granulosa cells, show that with 
age and exposure to specific diet and environmental toxins, their regulatory role 
is jeopardized leading to cell cycle abnormalities, meiosis defects and aneuploidy 
(Babayev and Seli, 2015) . Moreover, the presumed compensatory mechanisms 
leading to less devastating effects of ovarian surgery on ovarian reserve can be 
further explored in animal models. Knowing which genes and products are either 
up- or downregulated in the remaining ovary after unilateral oophorectomy may 
provide insight in how a reduced number of follicles is used optimally. These intra 
ovarian compensatory mechanisms may have a therapeutic potential to aid infertile 
patients and women who are at risk for shorter reproductive lifespan. The process of 
ovarian ageing is as yet irreversible but maybe with better fundamental knowledge 




The Declaration on Population of the United Nations declares that it is the choice of 
each individual to determine its family size (Ayala and Caradon, 1968). Free choice 
is illusory unless alternative possibilities are known. Unfortunately, most women 
are unaware that delaying childbearing increases the chances of involuntary 
childlessness (Präg et al., 2017). 
Sexual education programs are mandatory in many countries in Europe for already 
many decades. It has been introduced as early as 1956 in Sweden and in the 1970´s for 
most other countries (Bott, 2013). The content of these programs covers unwanted 
pregnancy, sexually transmitted diseases, abortion and contraception. Biological 
aspects such as sperm production, ovulation and fertilization are also explained. 
However, changes in reproductive fecundity with age are not discussed (Nargund, 
2015). The studies included in this thesis indicate that different conditions of 
diminished ovarian reserve have an impact either on adverse reproductive outcomes 
or reproductive lifespan. Moreover, it should be taught that IVF treatments cannot 
overcome conditions of diminished ovarian reserve. Additional to the traditional 
orientations received in schools regarding prevention of pregnancy, young women 
should know the effect of age and other conditions of diminished ovarian reserve 
on their fecundity. Once aware of the limitations of ovarian physiology, women are 
better equipped to decide when to start a family. 
However, it is cruel to disregard the social context and blame the individual choice 
for unwanted childlessness. In most professions, starting a family functions as a 
hold-back-penalty for women. In the academic field for example, compared to a 
male PhD, a female PhD is 38% less likely to enter a tenure track when becoming a 
parent prior to 5 years post-PhD (Mason and Goulden, 2002). On the other hand, 
women that do have children earlier in life are highly likely to be less educated and 
fall into the “fertility poverty trap”, which is the observed association between early 
motherhood and child poverty (Dixon and Margo, 2000).
Societal support and change of concept can be of great help to diminish female 
struggle in this area. For example, many countries have compulsory military service 
for men. In such countries, the societies are organized to allow men to devote one 
or more years to learn basic military skills, and once this period is completed, men 
return to their normal lives, sometimes with some advantages, like a basic salary, 
or increase in pension. Although this compulsory character of military services is 
changing to a voluntary character, this is a clear example of socially built acceptance 
governmental policy. Similar acceptance has to be built within societies on with 
regard to maternity and paternity leave, child care and return to work support. This 
may help couples to fulfil their wish to have the number of children they desire, but 
may also add in general to improve birth rates.
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Some countries are already taking action. Policies adopted by some governments to 
increase birth rates include family allowance, paternity leave, baby bonus, child tax 
allowance, subsidized child care among others (UN, 2011). These policies increase 
labour supply for women in all educational levels and increase the probability of 
having a child in 5-17% depending on country and policy (Boca, 2015). In Austria, 
for example, the chance of having a second child increased 15% with an additional 
year of parental leave benefits (Haan and Wrohlich, 2009).
However, policy makers must be cautious not to jump from birth limiting measures 
to an all-too-active pro-natal policy. The issue now is lack of awareness of female 
fecundity with increasing age and lack of social-economic gender equality, which 
should be addressed first. If and when couples try to start and have a family must 
remain a personal choice, made consciously and well-informed. 
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Starting a family later in life is a trend of the last decades. For women, delaying 
childbearing to their mid-thirties means trying to conceive in a period in which 
fecundity, i.e., the capacity to conceive is already declining. The decline in the 
capacity to conceive is associated with the loss of oocytes, the female germline 
cells. Women are born with a fixed number of oocytes and throughout their lifespan 
these oocytes are lost via ovulation or cell death. Eventually, the loss of oocytes 
results in menopause. The remaining number of oocytes of a woman to a certain 
time point is known as her ovarian reserve. As oocytes age, their quality diminishes, 
as can be inferred from a higher frequency of trisomic pregnancies or a miscarriages 
at older maternal age. 
Whether the loss of quantity of oocytes is associated with the loss of quality of 
oocytes is still under debate. This thesis tests the hypothesis that diminished 
ovarian reserve is associated with lower quality of the remaining oocytes, leading 
to an increased risk of miscarriage and trisomic pregnancy. 
In this thesis, three proxies are used for diminished ovarian reserve: 1) ovarian 
surgery, 2) a low oocyte yield in IVF treatment after controlled ovarian stimulation, 
and 3) in-utero cigarette smoke exposure, i.e., smoking of the mother while pregnant 
of the woman who is now under study. Trisomic pregnancy and miscarriage are 
used as proxies for the quality of the oocytes. Additionally, we hypothesized that 
in-utero cigarette smoke exposure, resulting in a reduction of the ovarian reserve, is 
associated with age at menopause later in the life of the women who were exposed 
in-utero. 
Summary of the chapters 
Chapter 2 describes a case-control study, using data from Danish national medical 
registries, on the association between ovarian surgery, as a proxy for diminished 
ovarian reserve, and the risk of trisomic pregnancy later in life, as a marker of 
decreased oocyte quality. Prior ovarian surgery was not associated with a higher 
risk of trisomic pregnancy.
Chapter 3 is also describes a case-control study, performed in Danish and Dutch 
women who underwent IVF treatment. The study tested the association between 
low oocyte yield after controlled ovarian stimulation in IVF and the risk of a 
subsequent trisomic pregnancy. Low oocyte yield was not associated with a higher 
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risk of trisomic pregnancy.
Chapter 4 presents a cohort study among IVF-treated Dutch women, investigating 
their first two IVF-cycles. The study tested the hypothesis that repeated low oocyte 
yield during IVF treatment is associated with a higher risk of having a miscarriage. 
Results showed that women with a low oocyte yield in both cycles more often 
experienced a miscarriage compared to women with twice a normal oocyte yield. 
Women with low oocyte yield in one cycle and normal oocyte yield in the other did 
not have an increased risk of miscarriage compared to women with normal oocyte 
yield in both cycles, irrespective of whether this low oocyte yield occurred in the 
first or second IVF cycle.
Chapter 5 describes an epidemiological study aimed at answering the question 
whether women who were exposed to cigarette smoke in-utero have a higher 
chance of having a miscarriage later in life. It included participants in a longitudinal 
study from Bristol, UK. The risk of having one miscarriage was not influenced by 
being exposed to cigarette smoke in-utero. However, the risk of having two or 
more previous miscarriages was higher for participants who were exposed in-utero 
compared to women who were not exposed. There was an interaction between 
in-utero cigarette smoke exposure and four factors: the number of packyears 
smoked by the participants themselves, passive cigarette smoke exposure from 
other household members, and age at first and last pregnancy of the participants. 
Participants exposed to cigarette smoke in-utero who were ever smokers themselves 
had an increased risk of miscarriage while participants who were exposed to 
cigarette in-utero but who were never smokers did not have an increased risk of 
miscarriage.
Chapter 6 also describes an epidemiological study among participants in the English 
longitudinal study. This study investigated whether women who were exposed to 
cigarette smoke in-utero have a higher chance of earlier menopause compared to 
women who were not exposed in-utero. Results showed that in-utero cigarette 
smoke exposure alone was not associated with earlier menopause. But in-utero 
exposed participants who were smokers themselves did have a higher risk of earlier 
menopause. Participants who were exposed to cigarette smoke in-utero but never 
smoked themselves did not have a higher risk of earlier menopause. 
Conclusion and reflection
Diminished ovarian reserve is a result of various mechanisms leading to a decrease 
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in the quantity of oocytes. The association between diminished ovarian reserve 
and decreased oocyte quality leading to adverse reproductive outcomes seems, to 
be dependent on the mechanism which led to the reduction of the follicle pool.
Ovarian surgery showed an effect on the quantity of oocytes only, without an 
effect on oocyte quality. Oocytes of women with repeated low oocyte yield in IVF-
treatment seem to be affected both in quantity and quality of their oocytes. Cigarette 
smoke exposure in-utero showed an effect on quality of the remaining oocytes as 
reflected by the increase risk of multiple miscarriages, but not on oocyte quantity, 
as reflected by menopausal age. This thesis shows that the relation between the 
decrease in oocyte quantity and oocyte quality with female age is a complex one. 
Future research into the underlying mechanisms of the natural decrease in ovarian 




Het starten van een gezin op latere leeftijd is een tendens van de laatste vier 
decennia. Bij de meeste vrouwen daalt de vruchtbaarheid echter vanaf hun mid-
dertiger jaren. Dit betekent dat vele paren proberen om zwanger te worden in 
een periode waarin de fecunditeit van de vrouw, dat wil zeggen de kans op een 
zwangerschap per cyclus, al afneemt. Deze afname in de kans op zwangerschap 
is geassocieerd met het verlies van eicellen. Vrouwen worden geboren met een 
beperkt aantal eicellen dat gedurende de reproductieve levensfase steeds verder 
afneemt door eisprongen en celdood. Het overgebleven aantal eicellen dat een 
vrouw op een bepaald moment nog heeft, wordt de ovariële reserve genoemd. 
Uiteindelijk leidt het verlies aan eicellen tot de overgang (menopauze). Behalve een 
afname in het aantal eicellen neemt ook de kwaliteit van deze eicellen af als de 
vrouw ouder wordt. Hierdoor neemt met het stijgen van de leeftijd haar kans op 
een zwangerschap met een chromosomale afwijking toe, met name de kans op een 
trisomie (bijvoorbeeld Down syndroom) of een miskraam.
Het is onduidelijk of de afname van het aantal eicellen, de ovariële reserve, in 
direct verband staat met de afname van de kwaliteit van de resterende eicellen. 
Dit proefschrift onderzoekt de hypothese dat een verminderde eicelvoorraad 
geassocieerd is met een lagere kwaliteit van de resterende eicellen, hetgeen leidt 
tot een verhoogd risico op een miskraam of trisomie zwangerschap.
In dit proefschrift worden drie afgeleiden voor verminderde ovariële reserve gebruikt: 
1) een operatie aan de eierstokken (ovariële chirurgie), 2) een lage hoeveelheid 
eicellen bij een IVF-behandeling met hormoonstimulatie en 3) blootstelling aan 
sigarettenrook in de baarmoeder, dat wil zeggen dat de moeder rookte toen ze 
zwanger was van de vrouw die wordt onderzocht. Als afgeleide van verminderde 
eicelkwaliteit zijn zwangerschap van een vrucht met een trisomie en miskraam 
gebruikt. Bovendien veronderstelden we dat blootstelling aan sigarettenrook in de 
baarmoeder door schade aan de eierstokken leidt tot een verminderde ovariële 
reserve vroeg in het leven en daardoor ook geassocieerd is met menopauze op 
jongere leeftijd.
Samenvatting van de hoofdstukken
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Hoofdstuk 2 beschrijft een case-control studie waarbij gebruik is gemaakt van 
gegevens uit nationale medische Deense registers. De studie evalueert de relatie 
tussen een eierstokoperatie in het verleden (als afgeleide van een verminderde 
ovariële reserve) en het risico op een trisomie zwangerschap later in het leven (als 
afgeleide van verminderde eicelkwaliteit). In deze studie was een eierstokoperatie in 
het verleden niet geassocieerd met een hoger risico op een trisomie zwangerschap.
Hoofdstuk 3 beschrijft eveneens een case-control studie waarbij gebruik is gemaakt 
van gegevens uit nationale medische Deense registers. Daarnaast werden gegevens 
gebruikt uit het OMEGA-project, een omvangrijke nationale Nederlandse studie 
onder vrouwen die IVF-behandeling hebben ondergaan. De studie onderzocht 
onder Deense en Nederlandse vrouwen of een laag aantal eicellen bij een IVF-
behandeling met hormoonstimulatie een verhoogd risico geeft op een trisomie 
zwangerschap na deze IVF behandeling. In deze studie was een eenmalige lage 
eicelopbrengst na IVF-behandeling (als afgeleide van verminderde ovariële reserve) 
niet geassocieerd met een hoger risico op trisomie zwangerschap.
Hoofdstuk 4 beschrijft een cohortstudie binnen hetzelfde Nederlandse OMEGA-
project. In de studie werd onderzocht of het tweemaal voorkomen van een lage 
eicelopbrengst na IVF-behandeling geassocieerd is met een hoger risico op een 
miskraam na IVF-behandeling. Vrouwen met een lage eicelopbrengst in twee 
opeenvolgende IVF-behandelingen hadden inderdaad vaker een miskraam ten 
opzichte van vrouwen met een normale eicelopbrengst. Vrouwen met eenmaal een 
lage eicelopbrengst hadden geen verhoogd risico op miskraam, ongeacht of dit in 
de eerste of tweede IVF-behandeling optrad.
Hoofdstuk 5 beschrijft epidemiologisch onderzoek naar blootstelling van het 
ongeboren meisje aan sigarettenrook in de baarmoeder en haar kans op een 
miskraam later in het leven. De studie onderzocht gegevens van deelneemsters 
aan een grootschalige studie uit het Verenigd Koninkrijk, het ALSPAC cohort. Het 
risico op één miskraam werd niet beïnvloed door blootstelling aan sigarettenrook 
in de baarmoeder. Het risico op twee of meer miskramen was echter hoger voor 
deelneemsters die in de baarmoeder waren blootgesteld aan sigarettenrook. 
Deelneemsters die zelf (ooit) rookten én in de baarmoeder waren blootgesteld aan 
sigarettenrook hadden wel een verhoogd risico op miskraam, terwijl dit niet gold 
voor deelneemsters die zelf nooit hadden gerookt.
Hoofdstuk 6 maakt ook gebruik van data uit het Engelse ALSPAC cohort. De studie 
onderzocht of vrouwen die in de baarmoeder waren blootgesteld aan sigarettenrook 
jonger in de overgang komen dan vrouwen van wie de moeder niet had gerookt. 
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Blootstelling aan sigarettenrook in de baarmoeder bleek niet geassocieerd met 
een jongere leeftijd bij menopauze. Deelneemsters die in de baarmoeder waren 
blootgesteld aan sigarettenrook maar zelf nooit rookten hadden gemiddeld geen 
jongere menopauze leeftijd, terwijl deelneemsters die (ooit) zelf rookten wel vaker 
jonger in de overgang kwamen.
Overwegingen en conclusie
Verminderde ovariële reserve is hoogstwaarschijnlijk het resultaat van verschillende 
mechanismen die leiden tot een afname van de hoeveelheid eicellen. De associatie 
tussen verminderde ovariële reserve en verminderde eicelkwaliteit, resulterend 
in ongunstige uitkomsten zoals miskraam, trisomie zwangerschap en een jongere 
leeftijd bij menopauze lijkt afhankelijk te zijn van het soort mechanisme dat leidde 
tot de vermindering van de ovariële reserve.
Ovariële chirurgie lijkt alleen een effect te hebben op het aantal eicellen maar niet 
op de eicelkwaliteit. Vrouwen met bij herhaling weinig eicellen bij IVF-behandeling 
lijken juist zowel een verminderd aantal eicellen te hebben als een verminderde 
eicelkwaliteit. De blootstelling aan sigarettenrook in de baarmoeder leidt tot een 
daling van de kwaliteit van de resterende eicellen, zich uitend in een hoger risico 
op meerdere miskramen, zonder dat het een effect heeft op de menopauze leeftijd. 
Dit proefschrift toont aan dat de relatie tussen de afname in de eicelhoeveelheid 
en de eicelkwaliteit met de leeftijd complex is. Onderzoek naar de onderliggende 
mechanismen van de natuurlijke afname van de ovariële reserve lijkt een goede 
volgende stap om de afname van de vrouwelijke vruchtbaarheid met het ouder 
worden beter te begrijpen.
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